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ABSTRACT 
Background   
Iron deficiency anemia (IDA) is a major nutrition related problem in China, especially 
affecting pregnant women, like in most developing countries. Deficiencies of vitamins 
also play an important role, such that iron, retinol and riboflavin deficiencies tend to 
coexist in anemic pregnant women. However, vitamin and/or mineral supplements 
are not routinely used by pregnant women at or below low income levels. Besides 
being an essential trace element, iron plays a central role in oxygen radical 
generation, whereas susceptibility during pregnancy is elevated. There is evidence 
that both iron deficiency and excess may result in free radical damage.  
 
Objectives 
Based on this background, objectives of this thesis were to investigate the current 
prevalence of anemia among pregnant women in different sites of China, and to 
describe the micronutrient status of anemic and non-anemic pregnant women in 
China. In addition, in anemic pregnant women, the effect of retinol and riboflavin 
supplementation on top of iron plus folic acid on anemia and changes in 
hematological status was assessed. Also oxidative stress and erythrocyte membrane 
fluidity were evaluated. Finally, we compared the effect of sodium iron 
ethylenediaminetetraacetate (NaFeEDTA) and ferrous sulfate on hemoglobin (Hb), 
iron bioavailability and oxidative stress.  
 
Subjects and Methods 
A total of 6413 women in their third trimester of pregnancy were recruited from five 
rural areas in China (years 2000~2003) for screening anemia or iron deficiency. A 
random subset was selected for measuring micronutrient status. In three 
supplementation trials, effects of iron, folic acid, retinol and riboflavin were assessed 
among anemic pregnant women. Outcomes included hematological status, 
micronutrient status and parameters of oxidative stress. Samples of fasting blood 
were collected from subjects before and at the end of the interventions for 
measurements. 
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Results 
The overall prevalence of anemia was 58.6%, ranging between 48.1%~70.5% in the 
five areas. Serum concentrations of micronutrients were significantly lower in anemic 
women than non-anemic women. After the 2-mo intervention, the increase of Hb 
concentration in the group, supplemented with iron and folic acid combined with 
retinol and riboflavin, was 5.4g/L greater than in the group with iron and folic acid 
only (p<0.001). The reductions in the prevalence of anemia (Hb<110g/L) and iron 
deficiency anemia were significantly greater in the groups supplemented with retinol 
and/or riboflavin than in the iron and folic acid group. Riboflavin and/or retinol 
supplementation significantly improved gastrointestinal symptoms and well-being. In 
addition, supplementation of iron combined with retinol and riboflavin significantly 
decreased levels of serum malondialdehyde, and increased activities of glutathione 
peroxidase and erythrocyte membrane fluidity as well. NaFeEDTA supplementation 
showed superior effectiveness.  
 
Conclusion and recommendations 
Deficiency of iron and micronutrients in combination appears to contribute to the high 
prevalence of anemia in pregnant women in rural China. Supplementation with iron, 
particularly in combination with vitamins improved hematologic status as well as 
oxidative stress. NaFeEDTA performed better than ferrous sulfate. Multi-
micronutrient supplementation may be worthwhile for pregnant women in rural China. 
Further studies on food-based or supplement-based approaches are warranted to 
decrease anemia of Chinese pregnant women in the third trimester. 
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Anemia is the most common disorder during pregnancy with estimates of global 
prevalence reaching over 40% (1). Iron deficiency anemia (IDA) is the most frequent 
micronutrient deficiency disease in developing countries like China, heavily affecting 
pregnant women. Although the diagnosis of anemia is fairly simple and the treatment 
is inexpensive, the prevalence of anemia remains high especially in poverty-stricken 
areas of China. Also, it is clear that deficiencies of vitamins play a role in IDA, like 
folate, vitamin A, and riboflavin (2,3). In fact, retinol and riboflavin deficiencies tend to 
coexist in anemic pregnant women in developing countries or impoverished settings 
(4). However, vitamin and/or mineral supplements are not routinely used by pregnant 
women particularly of low income groups. Iron is an essential trace element but plays 
a central role in generating harmful oxygen species as well. Its redox cycling 
promotes the Fenton reaction, producing the potent oxidant hydroxyl radical (5). 
Pregnancy is a condition exhibiting increased susceptibility to oxidative stress (6). In 
rats, both iron deficiency and excess result in free radical mitochondrial damage (7). 
This thesis will therefore focus on iron deficiency, which affects Chinese pregnant 
women living in poor areas, and on the effect of multiple micronutrient 
supplementation on anemia and on oxidative stress in anemic pregnant women. In 
this chapter we will discuss iron homeostasis, factors contributing to poor iron status 
of pregnant women, iron requirements in pregnancy and the effect of iron and other 
micronutrient supplements.  
 
IRON HOMEOSTASIS 
Most of the iron in the body is distributed within red blood cell (RBC) hemoglobin 
(65%). Approximately 10% is present in muscle fibers (in myoglobin) and other 
tissues (in enzymes and cytochromes). The remaining body iron is stored in the liver, 
macrophages of the reticuloendothelial system, and bone marrow (8). The human 
body has developed intricate but exquisitely controlled mechanisms to absorb, 
transport and store iron, thus ensuring a ready supply for cellular growth and 
function, but limiting its participation in reactions that produce free radicals and its 
availability to invading pathogens (9).  
 
Iron absorption and metabolism 
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Iron is found in food as either heme or non-heme iron. Heme iron, which makes up 
40% of the iron in meat, poultry, and fish, is well absorbed. Sixty percent of the iron in 
animal tissue and all the iron in plants are in the form of non-heme iron and are 
relatively poorly absorbed (9). Virtually all dietary non-heme iron is in the ferric form 
(Fe3+), which must first be reduced to the ferrous form (Fe2+) before it is transported 
across the intestinal epithelium by a transporter called divalent metal transporter 1 
(DMT-1). But the existence of other uptake pathways cannot be excluded (10). The 
absorption of non-heme iron is diminished by co-administration of phytates (high-fiber 
diets), tetracyclines, proton pump inhibitors and antacid medication, calcium, and 
phenolic compounds (coffee and tea). Heme iron is absorbed into enterocytes by a 
putative, not totally identified heme carrier protein 1, which is a membrane protein 
found in the proximal intestine, where heme absorption is greatest (11). Once 
internalized in the enterocytes, it is likely that most dietary heme iron is released in 
ferrous form by heme oxygenase to enter a common pathway with dietary non-heme 
iron before it leaves the enterocytes (12). Supplemental iron is usually provided as a 
ferrous salt which is absorbed directly. In order to reach the circulation, this metal 
must cross both the apical and basolateral surfaces of the enterocyte (13).  
Iron that is not transported into the circulation is sequestered in the storage protein 
ferritin, a spherical protein that keeps oxidized iron in a soluble and relatively non-
toxic form. The metal that does not enter the circulation is eventually lost as the 
enterocytes are sloughed into the gut lumen. If the body is in iron balance, only 0.1% 
of the total body iron is absorbed from the gut daily, since the body has no effective 
means of excreting iron. The regulation of absorption by the duodenum plays a 
critical role in iron homeostasis in the body (14). 
 
Dietary factors affecting iron status 
The amount of iron that is absorbed in the body can be influenced by a number of 
enhancers and inhibitors present in the diet. Among those enhancers, vitamin C 
(ascorbic acid) is one of the most important factors. It is well known that vitamin C 
can enhance iron absorption by reducing ferric iron to ferrous iron, a form of iron that 
is more soluble and therefore better absorbed by the body (15). In addition, vitamin C 
can help to overcome some of the negative effects of iron inhibitors and also has an 
active role in supporting the body’s iron metabolism by enhancing the solubility of 
iron (16). The addition of ascorbic acid to a juice enhanced Fe absorption and Fe 
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utilization in ferrous sulfate or micronized dispersible ferric pyrophosphate (poorly 
soluble) to ferrous sulfate (highly soluble) (17). Recent evidence suggests that 
regular oily fish consumption may also have a role in improving iron status. The oily 
fish appears to be acting as an enhancer to release iron from a phytate-rich meal 
(18). There are also many factors present in the diet that inhibit the absorption of 
non-heme iron. The first one is phytate. Phytates are components found in plants that 
can interfere with the body’s absorption of nutrients such as iron, generally in a dose-
dependent fashion. The typical Chinese diet rich in wholegrain can decrease the rate 
of iron absorption, thereby increasing the risk of iron deficiency. Eating cereals and 
foods that are fortified with extra iron may help to compensate for some of these 
effects (19). Iron-binding phenolic compounds (polyphenols) are important inhibitors 
of iron absorption too. It is shown that tea drinking, a common practice in China, can 
limit iron absorption, especially from non-heme sources, which is mainly attributed to 
its polyphenol content (20). Fruits, vegetables, cereals and dry legumes are also rich 
in polyphenols. Women, who lose iron through their menses and particularly those 
who eat a predominantly plant-based diet, may benefit from taking a daily 
multivitamin and mineral supplement that contains iron (21).  
 
IRON DEFICIENCY 
Iron is an essential micronutrient because it plays a vital role in oxygen transport, 
oxidative metabolism, cellular proliferation and many other physiological processes 
(9). Iron requirements are met by dietary iron or from existing body iron stores. 
Increased iron requirements, limited external supply, and increased blood loss may 
lead to iron deficiency (ID) and iron-deficiency anemia (IDA). Inadequate dietary iron 
intake eventually results in depleted body iron stores, which is presumed to indicate 
iron deficiency. ID occurs when iron stores mostly found in the liver, start to become 
depleted, while IDA arises when the production of red blood cells starts to diminish 
once the iron stores have been depleted.  
 
Iron deficiency in pregnancy 
Anemia in pregnancy, defined as a hemoglobin concentration (Hb) < 110 g/L, affects 
more than 56 million women globally, two thirds of them being from Asia (22). Some 
women are already anemic before pregnancy and some others become 
progressively anemic during pregnancy. The causes of iron deficiency and iron 
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deficiency anemia can be multi-factorial, but common causes are low dietary iron 
intake, poor absorption of iron from the diet, parasitic infections, which are more 
common in developing regions, and disease states such as intestinal bleeding. 
Anemia can be mild, moderate or severe and can cause weakness, tiredness and 
dizziness. A healthy non-anemic woman could progress to a state of low iron stores, 
then to iron deficiency (ID) with no anemia and finally to a clinical iron deficiency 
anaemia (IDA) (23). Pregnancy requirements of iron are low in the first trimester, but 
progressively increase to reach a maximum in the third trimester. It has been 
estimated that the daily iron requirement of a 55 kg pregnant woman increases from 
approximately 0.8 mg in the first trimester to 4–5 mg during the second trimester and 
>6 mg in the third trimester (24).  
IDA can lead to reduced work capacity, intellectual capacity and productivity and 
increased susceptibility to infection of pregnant women (25). It is estimated that 
anemia resulted in 3.7% of the cases of maternal death in Africa and 12.8% in Asia 
(26). Severe anemia is associated with adverse perinatal outcomes such as small for 
gestational age babies and preterm deliveries. The harmful effects of ID at birth also 
have long term consequences such as poor physical and mental growth continuing 
throughout childhood and adolescence, and even permanent neuro-physiological 
deficiencies (27-28). So, it is important to improve iron status during pregnancy.  
 
Prevention of iron deficiency in pregnancy 
In view of high prevalence of iron deficiency in pregnancy, it is postulated that weekly 
iron (60 mg of ferrous sulphate) and folic acid (3 mg) supplementation for women of 
reproductive age, including adolescent girls between 10–19 years old could be an 
effective strategy to achieve good iron stores before a woman becomes pregnant 
(29). It was demonstrated that a weekly iron and folic acid supplementation program 
for women of reproductive age has been effective in reducing the prevalence of 
anemia in some districts in Vietnam, the Philippines and Cambodia (30-32). In order 
to prevent adverse perinatal outcomes resulting from iron and folic acid deficiency in 
pregnant women, according to WHO a daily supplement of 60 mg of elemental iron 
and 400 μg of folic acid should be started as soon as possible by all pregnant women 
in communities where anemia during pregnancy is a significant problem. This should 
be given throughout pregnancy and continued for six months postpartum to ensure 
adequate iron stores in the woman (33). This regimen increases maternal 
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hemoglobin levels and the birth weight of the new born, and reduces the delivery of 
low birth weight babies.  
Ferrous iron, as sulfate or sodium iron EDTA (NaFeEDTA) is mostly used for 
correction of iron deficiency. Sodium iron EDTA is an iron chelate that was used 
successfully (34) and is not influenced by the inhibitors of iron absorption. It has a 
bioavailability 2 - 4 times that of ferrous sulfate (35). Nevertheless, NaFeEDTA and 
ferrous fumarate at low levels compatible with South African brown fortified bread (10 
mg/kg flour for NaFeEDTA and 20 mg/kg flour for ferrous fumarate) did not show 
effective improvement iron or Hb status in a randomized controlled trial (36,37). But a 
fortification level of 30 mg/kg FeSO4, and 20 mg/kg NaFeEDTA in wheat flour had a 
positive effect on iron status in anemic students in China, while NaFeEDTA was more 
effective than FeSO4 (38). However, few data have evaluated the impact of 
NaFeEDTA to control iron deficiency anemia (IDA) in anemic pregnant women.  
 
Retinol and IDA 
As early as the 1920s, vitamin A deficiency and anemia or other indices of low iron 
status were reported to be associated in humans and animals (39-40). Observational 
studies showed that serum retinol was positively associated with hemoglobin, 
hematocrit, and serum iron (41-42). Some studies also showed that vitamin A may be 
required for the mobilization and utilization of iron for hemoglobin synthesis, and thus 
contribute to erythropoiesis (43). A study conducted in Indonesia showed that 
antenatal iron and vitamin A supplements were better than iron alone (44). However 
studies in Malawi did not show a similar effect (21). Hodges’s study indicated that 
iron stores are unavailable for erythropoiesis during vitamin A deficiency which 
implies that vitamin A plays a role in the release of iron from the liver (45]. The data 
of an experimental study showed that in a population with low socioeconomic status, 
vitamin A supplementation (3.0mg/d) can improve the hematological condition 
(hemoglobin increased by 9 g/L) of anemic children (46).  
 
Riboflavin and IDA 
It’s indicated that iron deficiency is often accompanied by other micronutrient 
deficiencies including retinol and riboflavin (47-48). Riboflavin deficiency may be one 
of the most common vitamin deficiencies in regions, like rural areas in China, where 
diets are predominantly rice based and contain insufficient milk, meat, fish, and fresh 
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fruit and vegetables (49). Some animal studies have shown that iron absorption is 
impaired when riboflavin is deficient (50-51). Moreover, other studies (52-53) have 
shown better hematological response when riboflavin was given along with iron than 
when iron was given alone. A recent study also showed good correlations between 
blood hemoglobin and serum ferritin and dietary intakes of riboflavin (54). It has been 
shown that riboflavin has a direct role in the release of iron from ferritin (55-56). 
 
PREGNANCY, MICRONUTRIENT STATUS AND OXIDATIVE STRESS 
Pregnancy and oxidative stress 
Pregnancy is a condition exhibiting increased susceptibility to oxidative stress, 
defined here as a disturbance in the prooxidant-antioxidant balance in favor of the 
former, leading to potential damage (57). It has been suggested that pregnancy is a 
state of oxidative stress, which is characterized by the placental production of 
reactive oxygen species including superoxide and hydrogen peroxide (6,58,59); 
Placental cells are rich in mitochondria, which is a condition that favors oxidative 
stress.Transition metals, especially iron, which are particularly abundant in the 
placenta, are important in the production of free radicals (6). Excessive free radical 
production may cause both lipid and protein oxidation and impair normal endothelial 
cell function (60). The elevated oxidative stress could alter placenta and fetal skeletal 
formation as well (61). Pregnancy complications such as spontaneous abortion, 
recurrent pregnancy loss, and preeclampsia, can also develop in response to 
oxidative stress (62). Oxidative stress is also strongly involved in the pathogenesis of 
many preterm newborn diseases, such as the presence or absence of advanced 
retinopathy of prematurity, grade III intraventricular hemorrhage, respiratory distress 
syndrome, bronchopulmonary dysplasia, sepsis or severe fungal infection (63). This 
is due to the low efficiency of neonatal antioxidant systems unable to counteract the 
harmful effects of free radicals. Altered maternal micronutrients through oxidative 
stress may reduce neurotrophic factors in preterm pregnancy (64). Antioxidant 
enzymes such as superoxide dismutase (SOD) and glutathione peroxidase (GSH-px) 
could be beneficial in maintaining pregnancy by antagonizing the harmful oxygen free 
radicals (65,66).  
 
Iron status and oxidative stress 
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Iron deficiency anemia (IDA) can severely impair the outcome of pregnancy in 
animals. It increases the expression of hypoxia and inflammatory markers in the 
placenta, and may cause oxidative stress in pregnant animals, fetuses and 
placentas. Treatment with iron polymaltose complex/folic acid corrected the IDA as 
well as reduced the levels of oxidative stress and inflammatory markers close to 
nonanemic control values in all the studied organs (67). The relationships of oxidative 
stress and DNA damage with the severity of anaemia suggest that both oxidative 
stress and DNA damage may, in part, have a role in the pathogenesis of IDA (68). A 
systematic review (69) examined potential adverse effects of iron supplementation, 
including oxidative stress, inhibition of absorption of other nutrients, neonatal 
morbidity, the requirement for blood transfusion, and other adverse effects. None of 
the studies found any evidence that iron supplementation increased oxidative stress 
in low birth weight infants; however, two studies reported an increased incidence of 
respiratory tract infection with iron supplementation (70-71). IDA tends to increase 
the pro-oxidant components, which may result in various complications including 
peroxidation of vital body molecules resulting in increased risk for pregnant women 
as well as for the fetus (72). Iron deficiency anemia (IDA) affects not only the 
hematological parameters but also disturb the oxidative balance of body. In 
pregnancy, this is much more considerable as oxidative stress is considered to be 
one of the physiological changes during this period (73). 
 
Micronutrient status and oxidative stress 
Increased metabolic burdens during late gestation and lactation cause elevated 
systemic oxidative stress during these important periods. Increased oxidative stress 
is related to decreased availability of antioxidants during late gestation and lactation, 
which begin to normalize towards the end of the lactation period. It may be necessary 
to increase the vitamin E and A contents in the diet during the gestational period in 
order to compensate for the substantial loss of these nutrients (74). Serum alpha-
tocopherol, retinol, and malondialdehyde concentrations were measured at 7 months 
of pregnancy in 122 women from low socio-economic background. Preterm delivery 
was associated with low nutrient status especially vitamin A. The role of antioxidant 
nutrients, especially vitamin A and oxidative stress in relation to fetal growth and 
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pregnancy outcome among mothers from low socioeconomic settings requires 
attention (75). Vitamin A deficiency (VAD) is prevalent in developing countries  
(76), retinol equivalents and iron were the major nutritional problems in China (77).  
Overall, a few studies reported that pregnancy and abnormal environments, such as 
low intake of antioxidants or micronutrients, might enhance levels of oxidative stress, 
and be harmful to the outcome of pregnancy. Although some studies showed that 
development of pregnancy, and fetus and infant growth, and iron status may be 
related to oxidative stress, the oxidative stress status of pregnant women with iron 
deficiency and micronutrient deficiency is unclear. Adequate supplementation of iron 
for anemic pregnant women living on plant-diets is necessary to improve iron 
deficiency or iron deficiency anemia, and maintain iron stores; while vitamin 
supplementation may be important to improve iron absorption and utilization as well 
as oxidative stress level. Multiple micronutrient supplements might increase 
hemoglobin and improve nutritional status of pregnant women more than iron 
supplements alone or iron with folic acid (78). No consistent adverse effects of iron 
supplementation have been reported, although many studies did not monitor such 
effects. Therefore, further studies are needed on iron deficiency, and the potential 
adverse effects of iron supplementation, especially with respect to oxidative stress, in 
pregnancy. 
 
RATIONALE AND OBJECTIVES 
Study rationale  
Anemia is the scourge of the third world (79). The overall prevalence of anemia 
during third trimester of pregnancy was 48.2% during 1995-2000 (80). In fact, most of 
Chinese pregnant women live in rural areas with low socio-economic levels, and 
anaemia mainly is a problem there, and reports about the prevalence are limited. 
Therefore, we have performed a cross sectional study in five rural areas all over 
China, in order to get a more representative and complete picture of the prevalence 
and determinants of anemia. Furthermore, we carried out three experimental trials to 
investigate the effect of iron and micronutrient supplementation during pregnancy on 
anemia and nutritional status as well as possible effects on oxidative balance.   
Study objectives 
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This thesis is composed of five chapters in two parts: an observational and an 
experimental part. 
Observational part 
A cross-sectional study was carried out,   
1) to assess the prevalence of anemia in Chinese pregnant women, in five 
geographically different sites, see chapter 2; 
2) to describe the micronutrient status of anemic and nonanemic women in a 
subset of this population. In addition to iron deficiency anemia may be due to deficits 
of other micronutrients, see chapter 3. 
Experimental part 
Three randomized supplementation trials were designed:  
 1) To explore the effect of retinol and riboflavin supplementation on top of iron plus 
folic acid on anemia and subjective well being in pregnant women (chapter 4); 
2)To investigate changes in hematological status, oxidative stress and erythrocyte 
membrane fluidity in anemic pregnant women after iron supplementation with and 
without combined retinol and riboflavin (chapter 5); 
3) To evaluate effects of NaFeEDTA and ferrous sulfate on hematological status 
and oxidative stress in anemic pregnant women (chapter 6), in order to get evidence 
for superiority of one or the other supplement. 
 
STUDY SETTINGS 
Anemia remains a major problem in nearly all developing countries, and in the wide 
countryside and poverty-stricken areas of China. We selected five different 
geographical areas of China to investigate the iron status and anemia prevalence of 
pregnant women and micronutrient status. The five areas included rural areas of 
Qingdao in the east, Fuzhou in the southeast, urban areas of Lanzhou in the 
northwest and Guilin in the southwest, and a district of Liaocheng in central China.  
In our cross-sectional study, we investigated the prevalence of anemia among 
pregnant women in the third trimester in the five selected rural areas of China. The 
enrolled women did not experience abnormal bleeding and did not take iron and 
multivitamin supplements, do not smoke tobacco products or drink alcoholic 
beverages during pregnancy.  
Unlike Western societies, food is not routinely fortified with iron in rural areas of 
China, and green vegetables were scarce in the subjects’ diets during the winter 
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season. Therefore, we supplemented the anemic women with a capsule of iron, folic 
acid, retinol and/or riboflavin. Our supplementation trials were designed to be carried 
out in one of the previous five sites, Shen’ county located in the middle of China. The 
number of subjects in three trials was 366, 164 and 153 anemic pregnant women in 
the second trimester, respectively, who were randomly enrolled from the population 
of anemic pregnant women.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
Prevalence of anaemia and micronutrient status in 
Chinese pregnant women in 5rural areas  
prevalence of anemia, 
Hb, ferritin, iron, etc 
N=6413 
Nutritional status, retinol, 
iron, riboflavin, VB12, etc 
N=734 
Lanzhou, 
the Nothwest 
Guilin, the 
southwest 
Fujian, the 
south east 
Liaocheng, 
the middle 
Qingdao, 
the east 
Figure 1.1 Profile of the cross sectional study. 
CROSS-SECTIONAL STUDIES 
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①Treated groups: IF, 60 mg ferrous sulfate and 400μg folic acid (reference); IFA, additional 2 mg 
retinol; IFB, additional 1mg riboflavin; IFAB, additional both 2 mg retinol and 1mg riboflavin  daily. 
②Treated groups: C, placebo; I, 60mg iron as ferrous sulfate; IF, additional 400μg folic acid; IM, 
additional 400μg folic acid, 2 mg retinol and 1 mg riboflavin. 
③Treated groups: C, placebo; I, 60 mg iron as ferrous sulfate; IE, 60 mg iron as NaFeEDTA. 
Three supplementation trials 
among anaemic pregnant women in Shen’ county, China.  
①Treated groups IF, 
IFA, IFB, IFAB 
Figure 1.2 Profile of the randomized, double-blind controlled trials.  
Aims of the studies are to investigate the effects of supplementations with iron alone 
and iron combined with vitamins on anemia, micronutrient status and oxidative stress.  
2 month supplementation 
Haematological 
status, oxidative 
stress 
Haematological 
status, vitamin 
status 
Haematological 
status, oxidative 
stress 
1 
366 anemic subjects, 
Hb80-105g/L 
2 
164 anemic subjects, 
Hb <110g/L 
3 
153 anemic subjects, 
Hb<110g/L 
②Treated groups  
C, I, IF, IM  
③Treated groups 
 C, FeSO4, NaFeEDTA 
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Abstract 
Objectives: To investigate the current prevalence of anemia among pregnant women 
in different sites of China and the association with birth weight and educational level. 
Methods: A total of 6413 women aged 24~37 in the third trimester of pregnancy were 
randomly selected from all gravidas who gave a birth in the hospitals during 1999 to 
2003. Blood hemoglobin concentration (Hb) was measured by the 
cyanomethaemoglobin method. Hb<110 g/L result was considered as anemia.  
Results: The overall prevalence of anemia was 58.6%, ranging 48.1%~70.5% in the 
five areas. There was a significant difference in the prevalence of anemia between 
women who have mental jobs and those who have physical jobs (52.3% versus 
61.1%, p<0.01). The prevalence of anemia according to the level of education was 
also significantly different with 52.9%, 62.4% and 66.5%, respectively for college, 
secondary school and primary education.The association of Hb with birth weight 
showed a range of higher levels of birth weights during 90 to 140g/L of Hb. However, 
the lower birth weight was located below 80g/L and above140 g/L of hemoglobin 
concentrations.  
Conclusions: The prevalence of anemia in Chinese pregnant women before delivery 
was high in rural areas and towns. Resident areas, education levels, kinds of job all 
have an influence on the prevalence of anemia. The low maternal hemoglobin 
concentrations influenced the birth weight.  
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Introduction  
Anemia is the scourge of the third world (1). Anemia remains a major problem in 
nearly all developing and many industrialized countries (2). Pregnant women are at 
risk especially during the last trimester of pregnancy. The prevalence of anemia 
(Hb<110g/L) in Chinese pregnant women in the third trimester was 48% during 1995-
2000 (3), and the prevalence of iron deficiency (ID) and iron deficiency anemia (IDA) 
was 42% and 19%, respectively (4). Notwithstanding the fact that the diagnosis of 
anemia is fairly simple and the treatment is cheap, the prevalence of anemia remains 
high in developing towns, as well as in the wide countryside and poverty-stricken 
areas of China.  
In pregnant women, a favourable iron status is a prerequisite for a good course of 
pregnancy. There is evidence that iron deficiency, even in the absence of iron 
deficiency anaemia (IDA), may have a negative impact in non-pregnant women, e.g. 
in relation to decreased cognitive ability and physical performance (5). It may impair 
development of fetus and infants (6). Low maternal hemoglobin levels are associated 
with increased risk of preterm delivery and low birth weight (7,8). Prenatal 
prophylactic iron supplementation deserves further examination as a measure to 
improve birth weight and potentially reduce health care costs (9) A randomized 
controlled trial suggested that prophylactic iron supplementation begun in early 
pregnancy can reduce third-trimester anemia and improve birth outcomes (10). 
However, a recent study showed that anemia during early pregnancy was not 
associated with increased risk of adverse perinatal outcomes, and anemia in later 
pregnancy was inversely associated with preterm birth and low birth weight (11). 
Therefore, the relationship between hemoglobin concentrations and birth weight is 
still not clear. The purpose of this study is to investigate the current prevalence of 
anemia in geographically different locations in pregnant women in China, and 
describe the associations of hemoglobin concentrations with birth weights. 
 
Subjects and methods 
 
Subjects 
A cross-sectional study was designed. Because China has a large population and 
larger area, the 5 sites were randomly selected from a number of pregnant centers 
nationwide, which was rural areas of Qingdao in the east, Fuzhou in the southeast, 
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urban areas of Lanzhou in the northwest and Guilin in the southwest, and a suburban 
district of Liaocheng in the middle of China during 1999 to 2003. Also 6413 subjects 
were randomly enrolled by the order of registration numbers, 1, 5, 10, 15, 20, etc. for 
regularly pregnant examination from the local population of pregnant women. With 
respect to geographical and other conditions like lifestyle, they can be regarded as 
representatives of the large variation present in China, except for remote areas. 
Subjects included in the study were healthy pregnant women whose delivery ended 
between 35 and 42 weeks of gestation without delivery complications, such as 
hypertension. Furthermore, subjects did not experience abnormal bleeding, take iron 
and multivitamin supplements, smoke tobacco products, or drink alcoholic beverages 
during pregnancy. Demographic data were collected by questionnaires that were 
used routinely nation-wide at admittance to hospital for delivery. 6413 samples of 
venous blood were collected within one or two weeks before delivery for hemoglobin 
analysis.  
The protocol was approved by the ethical committees of local hospitals in five sites. 
Informed consent was obtained from each of pregnant women recruited.  
 
Method and Criteria for diagnosis of anemia 
Blood hemoglobin concentration was measured by the cyanomethemoglobin method 
within 2~4h (12). Based on the report of the International Anemia Consultative Group 
(13), Hb<110g/L was considered as anemia. 
Statistical analysis  
Differences were tested using Student’s t-test and the Chi-Square test. The SPSS 
(11.0) of statistical software was used. The percentile distributions of hemoglobin 
concentrations were compared among five sites. The association of hemoglobin 
concentrations and birth weight was described by simple line (summarizes for groups 
of cases). Two-sided p <0.05 were considered statistically significant.  
 
Results 
Among the 6413 pregnant women screened, the overall prevalence of anemia was 
58.6%. The prevalence within the five centers ranged from 48.1%~70.5% in Table 
2.1. Compared with sites of Liaocheng, Lanzhou and Guilin, there were higher rates 
of anemia in Fuzhou and Qingdao (p<0.001). The prevalence of anemia is shown 
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according to the type of jobs among 6140 and to educational levels among 4624 of 
the women. There was a significant difference in the prevalence of anemia between 
women has mental (52.3%) and physical jobs (61.1%, p<0.01). Moreover, the 
prevalence of anemia was significantly different according to educational level: 
52.9%, 62.4% and 66.5%, respectively for college, secondary and primary education 
(Table 2.2).  
 
Table 2.1 Prevalence of anemia and Hb distribution in five sites 
Sites 
Total 
number 
Anemia (%) 
Hb (g/L) distribution 
70 ~ ≤90 >90~ <110 ≥110 
Qingdao 1085 69.9 19.6 50.3 30.1 
Fuzhou 1023 70.5 20.3 50.2 29.4 
Liaocheng 2363 55.6 11.1 44.5 44.4 
Lanzhou 1003 51.3 7.7 43.6 48.7 
Guilin 939 48.1 5.2 42.9 59.1 
Total 6413 58.6 12.7 46.4 40.9 
 
Table 2.2 Prevalence of anemia according to work type and  
educationin pregnant women 
Items 
total  
number 
anemic 
number 
prevalence 
(% ) 
p 
Work types (n=6140) 
Mental    1339 700 52.3 <0.001 
Physical 4801 2942 61.1  
Educational level (n=4624)    
College 665 352 52.9  
Secondary school 2307 1439 62.4 <0.005 
Primary school 1652 1098 66.5  
 
The mean ages in the anemic and non-anemic group were similar (27.0 y and 27.1 
y). Fig 2.1 showed that the association of Hb with birth weight showed a range of 
higher levels of birth weights during 90 g/L to 140 g/L of Hb. However, the lower birth 
weight was located below 80 g/L and above 140 g/L of hemoglobin concentrations. 
The distribution of haemoglobin levels in the five centers. The distributions of 
hemoglobin concentrations of Qingdao, Fuzhou and Liaocheng were less favorable 
than those of Lanzhou and Guilin in Fig 2.2.  
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The association between birth weight and Hb values
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Figure 2.1 The association of average points of hemoglobin 
concentrations (Hb) with birth weight in 6413 pregnant women was 
shown on the curve. There was a range of higher levels of birth 
weights during 90 g/L to 140 g/L of hemoglobin concentrations. 
However, the lower birth weight on the curve was located below 80 
g/L and above 140 g/L of hemoglobin concentrations.  
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Figure 2.2 The figure shows the distribution of hemoglobin on five curves. 
The peaks of percentage of hemoglobin in Lanzhou (L) and Guilin (G) are 
at about 115 g/L, while other three peaks of hemoglobin in Qingdao (Q), 
Fuzhou (F) and Liaochen (C) are at about 95 g/L ~ 105 g/L. The difference 
among the peaks is about 10g/L ~ 20g/L.  
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Discussion 
In this study, we observed a very high prevalence of anemia in the third trimester of 
pregnancy. The results indicated that anemia in pregnant women was still a severe 
nutrition related problem nowadays. We hypothesized that reasons for the difference 
in prevalence among the five sites were geographic factors, unbalanced diets and 
poor nutritional education (14). People living in the countryside have lower incomes 
and less varied diets. Our study seems to indicate that there is still a high rate of 
anemia in rural areas. In more remote parts of China, it may be even worse.  
Anemia during pregnancy was defined according to WHO guidelines (Hb < 110 g/L), 
while nutritional anemia should include iron-deficiency anemia (IDA), cobalamin 
deficiency anemia, folate deficiency anemia, copper deficiency anemia, etc. The 
prevalence of nutritional anemia is considered to be related to deficiencies of multi-
nutrients (15), and more than 85% of the nutritional anemia is IDA alone, or of iron 
combined with folate or other nutrient deficiencies (16). The purpose of our study was 
expected to investigate the prevalence of overall anemia, which might show the 
status of multinutrients in addition to iron deficiency. A study showed that the subjects 
with iron-deficiency anemia had much higher rates of vitamin C, folate and vitamin 
B12 deficiencies than those in the non anemic subjects, and especially the deficient 
rates of ascorbic acid and folate in the anemia (Hb <110g/L) group reached 64.0% 
and 22.7% respectively. And the decreasing hemoglobin concentrations were 
accompanied by the decreases of serum levels of vitamin A, ascorbic acid, folate and 
vitamin B12. Somultiple vitamin deficiencies, especially ascorbic acid, retinol and folic 
acid, may be associated with anemia or iron deficiency in pregnant women in the last 
trimester. So the study suggested that anemic pregnant women in China should be 
supplemented with iron and multiple vitamins simultaneously (17). 
The level of education may influence the health and nutritional status of individuals. 
Abel et al (18) reported that combination of education and iron supplementation could 
improve the hematological status among each of the three trimesters of pregnant 
women in a rural community. They reported a significant decrease in the prevalence 
of anemia among women in all trimesters in the intervention areas. Some other 
researchers reported that there were no statistically significant differences in IDA 
perceptions and iron-related dietary practices based on education, and relatively few 
based on where participants live, their available financial resources, or their position 
(pregnant women or young women) (19). Bondevik (20) found that the risk of anemia 
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increased with duration of pregnancy. Work within the service professions, higher 
education and higher body mass index were associated with a lower risk of anemia. 
A similar study, about the effect of nutritional education on anemia and malnutrition of 
infants and children in rural China, was carried out in the past five years. After one 
year, the education group mothers showed significantly higher nutrition knowledge 
and reported better infant feeding practices than the control group. Type of job was 
also related to the prevalence of anemia. A likely explanation might be that women 
with mental job have better education, incomes and living conditions.  
Strong evidence exists for an association between maternal hemoglobin 
concentration and birth weight as well as between maternal hemoglobin 
concentration and preterm birth (21). Although high hemoglobin (>120 g/L) during the 
second and third trimester significantly increased the risk of low birth weight 
(RR=3.11) (22), mild and moderate anemia did not increase the risk of preterm 
delivery and low birth weight statistically (23). The lowest incidence of preterm 
delivery and low birth weight was found among pregnant women with Hb levels at 
90g/L-~99 g/L. The risk for preterm delivery and low birth weight increased with either 
increasing or decreasing hemoglobin concentrations. Women with severe anemia 
(Hb< 70 g/L) had 80% higher risk of preterm delivery and a 4-fold higher risk of low 
birth weight compared with women with an Hb value of 90g/L ~99 g/L. In addition, 
women with a high Hb concentration (Hb>130 g/L) had 20% higher of preterm 
delivery and 50% higher risk of low birth weight (23). Moreover, in this study, the 
distribution of hemoglobin concentrations showed that both lower (Hb<80g/L) and 
higher hemoglobin concentrations (Hb>140 g/L) might result in deviating from the 
normal birth weight (2500g~4000g). Birth weight correlates negatively with maternal 
hemoglobin concentration. Anemia (by causing hypoxia) and iron deficiency (by 
increasing serum norepinephrine concentrations) can induce maternal and fetal 
stress, which stimulates the synthesis of corticotropin-releasing hormone (CRH). 
Elevated CRH concentrations are a major risk factor for preterm labor, pregnancy-
induced hypertension and eclampsia, and premature rupture of the membranes. 
CRH also increases fetal cortisol production, and cortisol may inhibit longitudinal 
growth of the fetus. An alternative mechanism could be that iron deficiency increases 
oxidative damage to erythrocytes and the fetoplacental unit. Iron deficiency may also 
increase the risk of maternal infections, which can stimulate the production of CRH 
and are a major risk factor for low birth weight and preterm delivery (24). Association 
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between maternal hemoglobin concentration and birth weight needs more attention 
because reducing the incidence of low birth weight not only lowers infant mortality 
rates but also has multiple benefits over the life cycle.  
Conclusion 
The high prevalence of anemia in pregnant women is still a national wide nutritional 
problem in China. In rural areas the situation seems to be less favorable than in 
urban areas, partly because of lower socioeconomic status, low education and 
training. Although this study showed higher hemoglobin concentration might cause 
birth weight decrease or increase, it deserves to be confirmed in the further study. 
Therefore, it is suggested that the normal hemoglobin concentration is important to 
pregnant women, fetus growth and birth weight as well.  
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ABSTRACT 
Background: Anemia is a major nutrition related problem in China. In addition to iron 
deficiency, this may be due to deficits of other micronutrients.  
Objective: To describe the micronutrient status of anemic and non-anemic pregnant 
women in China. 
Subjects and Methods: 734 clinically normal pregnant women in the third trimester 
aged 20~35 were randomly recruited in four provinces of China.Serum 
concentrations of vitamins A, B12 and C, iron and zinc status parameters, and vitamin 
B2 in urine were determined. Subjects were categorized according to the presence or 
absence of anemia and compared according to micronutrient status.  
Results:Serum concentrations of iron status and micronutrients were significantly 
lower in anemic women than nonanemic women: ferritin 13.8µg/L versus 19.6µg/L; 
vitamin C 308.9µg/dL versus 388.1µg/dL, retinol 50.0µg/dL versus 59.3µg/dL and 
vitamin B2 in urine 131.2µg/g creatinine versus 164.9µg/g creatinine. Iron and zinc 
concentrations were also lower in anemic women. Serum subnormal iron (<700µg/L) 
and iron depletion (ferritin <12 µg/L) were significantly more frequent in anemic than 
in nonanemic subjects, as were subnormal vitamin A and ascorbic acid. Subnormal 
vitamin B2 and B12 were frequent in both anemic and nonanemic groups.  
Conclusion: Subnormal concentrations of iron and micronutrients in combination 
may contribute to this situation. Further studies on food-based or supplement-based 
approaches trying to increase intake of iron and certain vitamins are warranted to 
decrease anemia of Chinese pregnant women in the third trimester. 
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INTRODUCTION 
Anemia in pregnancy is a common and worldwide problem that deserves more 
attention. In many developing countries, prevalence is reported even as higher as 
75%. Often, anemia is severe in these situations, contributing significantly to 
maternal mortality and morbidity1 and to low birth weight as well 2. Anemia is also a 
major nutrition related problem among pregnant women in China. Prevalence of 
anemia differs in different areas of China. Studies show that the prevalence of 
anemia during pregnancy is 10% to 20%. It is even 42% among pregnant women in 
the third trimester in Xi’an city3, and 55% in Jilin’s city in 1997. It was hypothesized 
that the main probable cause was unbalanced diet lack of protein, iron and certain 
vitamins4.  
Anemia during pregnancy has been attributed not only to increased iron 
requirements during the second and the third trimester of gestation5, but also to 
micronutrient deficiency. Deficiencies of iron and vitamin A were among the major 
contributory factors 6. Several studies in humans and animals have shown that iron 
deficiency is accompanied with other micronutrient deficiencies like vitamin A and 
ascorbic acid7,8. Studies also have shown that supplementation with these vitamins 
may improve iron status as measured by hematological indices 9. However, data on 
iron status and multivitamin levels in pregnant women with anemia in China are 
insufficient. In this study, we assessed and compared the micronutrient status of 
pregnant women with anemia and those without anemia. 
 
SUBJECTS AND METHODS 
 
Subjects 
The cross-section study was designed and conducted between November 1999 and 
April 2001. 734 clinically normal pregnant women aged 20-35 in the third trimester of 
pregnancy were randomly recruited for hematologic and micronutrient 
measurements, who were from several local clinics and hospitals in Gansu, the 
northwest of China; Guangxi, the southwest,Shandong, the northeast and Fujian, the 
southeast of China. The subjects were healthy pregnant women who did not 
experience abnormal bleeding and did not smoke or drink any alcoholic beverages, 
and no dietary supplements during 2 months. 
The study was approved by the Research and Ethics Committee of the Institute of 
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Human Nutrition, Medical College of Qingdao University. The informed consent was 
obtained from all subjects prior to the trial. 
 
Sample collection and biochemical analysis  
Approximately 5 ml of venous blood and 10 ml of urine samples were taken on the 
day of the prenatal examination, and stored in ice for transport to the local 
laboratories of the four sites. Hematocrit and hemoglobin concentrations were 
measured in heparinized blood. Serum was separated from the remainder of the 
blood by centrifugation at 2000 × g for 15 min at room temperature upon arrival. 
Serum samples were stored separately at -80 0C in the dark and transported by air or 
train to the laboratory of the Institute of Human Nutrition, Medical College of Qingdao 
University for analyses of ferritin, vitamin A, ascorbic acid, riboflavin, vitamin B12 and 
folate.  
Hemoglobin concentration was measured by the cyanomethemoglobin method and 
hematocrit by the micromethod. A standard hemoglobin cyanide solution was used 
for the quality control of hemoglobin measurements. Measurements of serum ferritin 
were performed by radioimmunoassay 10, described by the manufacturer (The North 
Biol.Tec, Institute Beijing, China). Transferrin (TRF) was determined by a 
commercially available kit (Yadu Biotech Co. Shanghai, China). Serum retinol 
concentrations were measured by reversed-phase high-performance liquid 
chromatography (HPLC) (Beckman 5000 with detector of 168, USA)11 and the within-
assay and between assay CVs were 3% and 8%, respectively. The nutritional status 
of riboflavin was determined by the ratio of urine riboflavin/creatinine, and the 
erythrocyte glutathione reductase activity coefficient (EGRAC) was measured for 
assessing riboflavin status12. Urinary riboflavin was measured by fluorometric 
procedures. Under conditions of adequate intake, the amount excreted per day is 
more than 80 g per gram of creatinine. Folic acid and vitamin B12 were measured by 
radioimmunoassay method (Diagnostic Products Corporation DPC, USA) 13. Serum 
concentrtions of iron, zinc and copper were measured by 710-ES ICP Optical 
Emission Spectrometer (Varian Medical System, USA). 
Based on the report of the International Anemia Consultative Group 14, the criterion 
for a diagnosis of anemia was Hb<110 g/L. The following results were considered 
abnormal: hematocrit <33%, ferritin <12 g/L, transferrin <2.1 g/L. The following 
values were considered subnormal: serum iron <700 g/L, vitamin A <30g/dL, 
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ascorbic acid <400 g/dL, riboflavin/creatinine <80 g/g in urine, folic acid <3.0 
ng/mL and vitamin B12<200pg/mL
15. 
 
Statistical analysis  
The significance of differences was determined by Independent Samples t-test and 
by the Chi-Square (χ2) test. The SPSS (10.0) of statistical software was used. The 
percentile distributions of serum iron, ferritin, folic acid, retinol, ascorbic acid and 
vitamin B2 were compared between anemic and nonanemic women. Two-sided p 
values <0.05 were considered statistically significant. 
 
RESULTS 
Results with respect to iron status in Table 3.1 showed that there were significant 
differences of serum hemoglobin (-24%), ferritin (-30%), transferrin (-6%) and serum 
iron (-18%) between anemic and nonanemic pregnant women. Mean concentrations 
of serum vitamin C (-20%), zinc (-5%), retinol (-16%) and vitamin B2 in urine (-21%) 
in the anemia group were significantly lower. There were no significant differences of 
serum copper levels, vitamin B12 and folate.  
 
Table 3.1 Iron status and micronutrient levels in anemic and nonanemic pregnant women 
Items 
Hb<110g/L Hb≥110g/L Difference 
(%) 
p 
n mean±SD n mean±SD 
Haemoglobin (g/L) 403 97.0±8.5 331 127.6±11.7 -24.0 0.000 
Haematocrit (l/L) 403 30.9±5.1 331 37.1±5.3 -16.7 0.000 
Ferritin (µg/L) 403 13.8±9.2 331 19.6±16.0 -29.6 0.000 
Transferrin(g/L) 403 3.3±0.5 331 3.5±0.5 -5.7 0.000 
Retinol (µg/dL)                      403 50.0±15.6 331 59.3±13.9 -15.7 0.000 
Vitamin C(µg/dL)           403 308.9±258.8 331 388.1±318.5 -20.4 0.001 
Vitamin(B12(pg/mL)              403 439.6±274.2 331 433.3±255.6 1.4 0.749 
Folate (ng/mL) 403 5.9±5.8 331 6.0±5.2 -1.7 0.914 
vitaminB2/creatinine(µg/g)           403 131.2±132.7 331 164.9±191.5 -20.5 0.005 
Iron (µg/L) 403 909.2±479.7 331 1108.9±748.9 -18.0 0.000 
Zinc (µg/L)  403 706.7±197.3 331 744.8±213.7 -5.1 0.012 
Copper(µg/L) 403 1758.9±543.1 331 1814.9±499.3 -3.1 0.149 
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Table 3.2 Prevalence of subnormal micronutrients in anemic and nonanemic women 
Items 
Subnormal 
range 
Anemia 
Non-
anemia 
Total 
p 
n % n % n % 
Serum iron                       <700g/L 160 39.7 97 29.3 257 35.0 0.003 
Ferritin                            <12µg/L 212 52.6 116 35.0 328 44.7 0.000 
Vitamin C                     <400µg/dL 279 69.2 202 61.0 481 65.5 0.020 
Retinol                          <30µg/dL 91 22.6 24 7.3 115 15.7 0.000 
Vitamin B12    <200 pg/mL 56 13.9 37 11.2 93 12.7 0.271 
Folate <3.0 ng/mL 108 26.8 78 23.6 186 25.3 0.316 
vitaminB2/ 
creatinine 
<80 g/g 159 39.5 121 36.6 280 38.1 0.421 
 
The frequency of subnormal serum iron and micronutrients is shown in Table 
3.2.  Prevalence of subnormal serum iron (<700µg/L) and iron depletion (ferritin <12 
µg/L) was 40% and 53% in the anemic group, compared to 29% and 35% in the 
nonanemic group (p<0.003, p<0.001). Subnormal vitamin A (23% versus 7%) and 
subnormal ascorbic acid (69% versus 61%) were also significantly more frequent in 
anemic pregnant women (p<0.001, p<0.02). Nevertheless, with 38% and 25%, 
frequencies of subnormal riboflavin and folate were not significantly different. 
The percentile distribution of iron status and vitamin concentrations according to 
presence or absence of anemia is presented in Figure 3.1 and showed more 
differentiated pictures of serum ferritin, serum iron, serum ascorbic acid, serum 
retinol, and vitamin B2/creatinine in urine. Moreover, the curves of Hb<110g/L and 
Hb≥110g/L in ferritin, serum iron, vitamin C and vitamin B2/creatinine overlap in the 
lower end of the distribution, while the upper end is distinct. However, the retinol 
distributions were entirely distinct for non-anemic and anemic subjects, and there is 
no difference in serum folate between non-anemic and anemic subjects. 
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(a)                                                                   (b) 
 
 
 
 
 
 
 
 (c)                                                                     (d)  
 
 
(e)                                                                    (f) 
 
 
 
 
 
 
 
 
Figure 3.1 The distributions of concentrations of ferritin (a), serum iron (b), serum vitamin C (c), 
vitamin B2 in urine (d), serum retinol (e) and serum folate (f) according to presence or absence of 
anemia are presented both in Hb<110 and Hb110.  
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DISCUSSION 
The results investigated in part of Chinese rural areas and low-economic towns 
showed that anemic pregnant women (Hb<110g/L) had a lower serum iron 
concentration, ferritin and transferrin levels than those in non-anemic group; 
moreover, micronutrients were significantly lower in anemic women than non anemic 
women in serum vitamin C, serum retinol and vitamin B2 in urine. Serum subnormal 
vitamin A and ascorbic acid levels were significantly more frequent in anemic than in 
non anemic subjects. 
The study has several advantages over previous studies that examined micronutrient 
status during pregnancy. Apart from having a large sample size, a wide range of 
micronutrients was examined simultaneously in Chinese rural areas. In addition, we 
reported the extent to which multiple deficiencies coexist, data that are scarce in a 
mixture of rural developing country settings and towns. The results in our study also 
have the potential to provide valuable reference values for assessing nutritional 
status. However, the assessment of vitamin and mineral status during pregnancy is 
complicated because there is a general lack of pregnancy-specific laboratory indices 
for nutritional evaluation16, and pregnancy itself may alter.  
However, this study was a pilot study on the small scale by a small grant. The 
subjects selected were from the population living in low or middle socio-economic 
levels and undeveloped areas, which was expected to be on behalf of an average 
status of micronutrients and anemia in part nationwide. The information of the 
characteristics and rates of anemia and iron deficiency of the subjects has been 
prepared for publication in another paper; while the stratified study may need a larger 
population by areas, which will be designed on the larger scale and supported by a 
big grant we expected. 
Although the most common cause of anemia is iron deficiency, deficiencies of 
vitamin B12, folate, vitamin A and even zinc contribute either singly or in combination 
to maternal anemia17. Women in developing countries have a high prevalence of iron 
deficiency but also tend to be deficient in other micronutrients such as zinc (5), 
vitamin A, folate and vitamin B12. However, iron deficiency rarely occurs in isolation 
and is often accompanied by other micronutrient deficiencies18. Makola19 confirmed 
that micronutrient deficiencies are prevalent in the female population of Tanzania and 
the prevalence of anemia (63%). In our study, low levels of serum vitamin C, retinol 
and riboflavin, occurred both in the anemia and non anemia populations, but the 
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three vitamin marginal deficiencies were more severe in pregnant women with 
anemia than non anemia, which should be contributed to the extra consumption by 
the fetus and pregnant women, and low intakes. The subjects in the investigation 
could not get enough green vegetables and animal foods20. Unlike Western societies, 
food is not routinely fortified with iron in rural areas of China. Moreover, green 
vegetables were scarce in the subjects' diets during the winter season. Therefore, the 
low intakes and shortage of heme iron and fresh vegetables may contribute to low 
serum average levels of retinal, ascorbic acid and low iron in anemic women in our 
study. Retinol status is a putative factor for improved iron status or iron absorption. 
Deficiency of this vitamin may result also in anemia in humans and animals that can 
be reversed only by vitamin A supplementation21. Vitamin A and β-carotene may form 
a complex with iron, keeping it soluble in the intestinal lumen and preventing the 
inhibitory factors on iron absorption 22. Ascorbic acid is considered a promoter of non-
heme-iron absorption. In the Chinese general diet, vegetables are commonly 
stratified, and fresh fruits are seldom eaten with a meal. Therefore, the amount and 
availability of vitamin C present in the diet are even more compromised by heat 
susceptibility explaining low serum concentrations of vitamin C both in anemic and 
non anemic women. Simultaneous occurrence of both vitamin C and iron in the gut is 
necessary for effective interaction23. In this study, there were 11.2% and 13.9 % of 
subnormal vitamin B12 (<200 pg/mL) in anemic and non anemic pregnant women 
respectively, which may have confounded the enhancing effect of ascorbic acid on 
iron status24. Vitamin B2 in urine, estimated by a ratio of vitamin B2 and creatinine, 
was also found to be lower in anemic women than in non anemic women. Subnormal 
folate was not prevalent in this study though it is associated with anemia and other 
micronutrient deficiencies. It may also be the result of low intake decreased intestinal 
absorption, or increased demand25,26.  
The serum zinc and iron concentrations were positively related with maternal 
hemoglobin27. The distributions of hemoglobin concentration to zinc and iron 
indicated that deficiencies of the two elements were common and more severe in 
anemic pregnant women. The possible reason is not only an expansive blood volume 
and an increasing need of zinc and iron for pregnant women, but also the poor intake 
and low bioabsorption of zinc and iron. Zinc supplementation may improve 
pregnancy outcomes for chronically deficient pregnant women. Prophylactic doses of 
20~25 mg elemental zinc per day have generally been used in pregnant women in 
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developing countries28. But we should also pay attention to the supplementation 
because iron can interfere with the absorption of zinc. Adverse effects on zinc 
metabolism were observed after ingestion of 100 mg Fe/d. An increase in the 
efficiency of zinc absorption was observed during late pregnancy29. 
In conclusion, in this multi-center cross sectional study we observed a very high 
prevalence of anemia in the third trimester of pregnancy in rural areas and suburban 
area as well. There was a high prevalence of anemia in Chinese pregnant women, 
and the prevalence of iron deficiency (ID) and iron deficiency anemia (IDA) was 42% 
and 19%, respectively30. These women often show poor nutritional status, lacking 
sufficient dietary intake of multiple micronutrients. The present study indicated that 
anemia in pregnant women was still a severe possibly nutrition related problem 
nowadays. It was hypothesized that the possible reasons for the difference in 
prevalence between the four sites were geographic factors, unbalanced diets and 
poor nutritional education4. Furthermore, concentrations of serum ferritin, iron, retinol, 
zinc and urinary excretion of riboflavin were lower in anemic women than in non-
anemic women. This may be the consequence of an unbalanced diet with a low 
amount of iron and micronutrients. Therefore, the supplementation of a combination 
of iron and other micronutrients should be encouraged for pregnant women and be 
more beneficial to anemic pregnant women in the third trimester as well. 
 
ACKNOWLEDGEMENTS 
We sincerely acknowledge professors Joseph Hautvast and Dr Paolo Suter for their 
kindly help. The authors also thank Zhang Xiuzhen, Liang Hui, Du Wei, Xu Hongwei, 
and Zhang Shehua for measuring and technical assistance. Thank Wang Xin for 
managing the contacts with subjects. There are no conflicts of interest and the 
manuscript has been read and approved by all authors. We sincerely acknowledge 
the Nestlé Foundation for the grant to this study. 
 
 
 
 
 
 
 
Micronutrient status in third trimester of pregnancy 
 
 49 
References 
1. van den Broek N.Anemia and micronutrient deficiencies. Br Med Bull. 2003; 67: 149-160. 
2. Ramakrishnan U. Nutrition and low birth weight: from research to practice. Am J Clin Nutr. 
2004; 79 (1): 17-21. 
3. Jin H, Han Q, Liang CA, Li L, Wu YZ, Zhao Q. The epidemiologic study of iron deficiency 
in pregnang women. Journal of Xi'an Medical University. 1995;16(4): 437-439. 
4. Liu LJ, Lai YH, Hu ZH. Investigation of anemia of 158 pregnant women in Jilin city. JiLin 
YiXueYuan XueBao. 1998;18(1): 45-47. 
5. International Anemia Consultative Group (INACG). Iron deficiency in women. Washington, 
D.C. The Nutrition Foundation 1981: 5-36. 
6. Brabin BJ, Prinsen-Geerligs PD, Verhoeff FH, Fletcher KA, Chimsuku LH, Ngwira BM, 
Leich OJ, Broadhead RL. Haematological profiles of the people of rural southern Malawi: 
an overview. Ann Trop Med Parasitol. 2004; 98(1): 71-83. 
7. Mejia LA, Hodges RE, Rucker RB. Clinical signs of anemia in vitamin A deficient rats. Am 
J Ciin Nutr. 1979; 32(7): 1439-1444. 
8. Makola D, Ash DM, Tatala SR, Latham MC, Ndossi G, Mehansho H.A micronutrient-
fortified beverage prevents iron deficiency, reduces anemia and improves the hemoglobin 
concentration of pregnant Tanzanian women. J Nutr. 2003; 133(5): 1339-1346. 
9. Bloem MW, Wedel M, van Agtmaal EJ, Speek AJ, Saowakontha S, Schreurs WH. Vitamin 
A intervention: short-term effects of a single, oral, mass dose on iron metabolism. Am J 
Clin Nutr.1990; 51(1): 76-79. 
10. Chu SL, Chen YZ, Xue JZ, Ni QG, Wang YL. Measurement of clinical application of 
ferritin by radioimmunoassay. Chin J Hematol. 1983; 4: 296-298. 
11. Handelman GJ, Shen B and Krinsky NI. High resolution analysis of carotenoids in human 
plasma by high-performance liquid chromatography. Methods Enzymol 1992; 213:336–46. 
12. Sauberlich HE, Judd JH, Jr. Nichoalds GE, Broquist HP, Darby WJ. Application of the 
erythrocyte glutathione reductase assay in evaluating riboflavin nutritional status in a high 
school student population. Am J Clin Nutr. 1972;25:756–62. 
13. Magnus EM, Bache-Wiig JE, Aanderson TR, Melbostad E. Folate and vitamin B12 
(cobolamin) blood levels in elderly persons in geriatric homes. Scand J Haematol. 1982; 
28(4): 360-366. 
14. WHO. Maternal health and safe motherhood program. The prevalence of anemia in 
women: A tabulation of available information.2nd ed. Geneva，Switzerland: World Health 
Organization, 1992. (WHO/MCH/MSN/92.2). 
15. Shile ME, Olson JA, Shike M. Modern Nutrition in health and disease. 2000; Eighth 
Edition: 287-450. 
16. Jiang T, Christian P, Khatry SK, Wu L, West LP. Micronutrient Deficiencies in Early 
Chapter 3 
 
 50 
Pregnancy Are Common, Concurrent, and Vary by Season among Rural Nepali Pregnant 
Women1J Nutr. 2005;135:1106–1112. 
17. Van den Broek NR, Letsky EA. Etiology of anemia in pregnancy in South Malawi. Am J 
Clin Nutr. 2000; 72: 247S–256S. 
18. Azais-Braesco V, Pascal G. Vitamin A in pregnancy: requirements and safety limits. Am J 
Clin Nutr 2000; 71: 1325S–1333S. 
19. Makola D, Ash DM, Tatala SR, Latham MC, Ndossi G and Mehansho H. A Micronutrient-
Fortified Beverage Prevents Iron Deficiency, Reduces Anemia and Improves the 
Hemoglobin Concentration of Pregnant Tanzanian Women. J Nutr. 2003;133:1339–1346. 
20. Ma AG, Chen XC, Zheng MC, Wang Y, Xu RX, Li JS. Iron status and dietary intake of 
Chinese pregnant women with anemia in the third trimester. Asia Pac J Clin Nutr. 
2002;11(3): 171-175 
21.Bloem MW, Wedel M, Egger R, Speek A J, Shrisjver J. Ironmetabolism and vitamin A 
deficiency in children in the NorthwestThailand. Am J ClinNutr. 1989; 50(2): 332-338. 
22. Semba RD, Bloem MW. The anemia of vitamin A deficiency: epidemiology and 
pathogenesis. Eur J Clin Nutr. 2002; 56(4): 271-281. 
23. Lynch SR, Dassenko SA. Morck TA, Beard JL, Cook JD. Soy protein products and heme 
iron absorption in humans. Am J Clin Nutr.1985; 41(1): 13-20. 
24. Garcia OP, Diaz M, Rosado JL, Allen LH. Ascorbic acid from lime juice does not improve 
the iron status of iron-deficient women in rural Mexico. Am J Clin Nutr. 2003; 78(2): 267-
273. 
25. Czeizel AB. Folic acid in prevention of neural tube defects. J Pediatr Gastroenternol Nutr. 
1995; 20(1): 4-16. 
26. Ladipo OA. Nutrition in pregnancy: mineral and vitamin supplement. Am J Clin Nutr. 2000; 
72 (suppl): 280s-290s. 
27. Hotz C, Lowe NM, Araya M, Brown KH. Assessment of the trace element status of 
individuals and population: The example of zinc and copper. J Nutr. 2003;133 (5 Suppl 1): 
1563s-1568s. 
28. Gibson RS, Ferguson EL. Nutrition intervention strategies to combat zinc deficiency in 
developing countries. Nutr Res Rev. 1998; 11:115-131. 
29. Linda J Harvey, Jack R Dainty, Wendy J Hollands, Victoria J Bull, John H Beattie, Tony I 
Venelinov, et al. Effect of high-dose iron supplements on fractional zinc absorption and 
status in pregnant women. Am J Clin Nutr. 2007; 85(1): 131-136. 
30. Liao QK. Prevalence of iron deficiency in pregnant and premenopausal women in China: 
a nationwide epidemiological survey. Zhonghua Xue Ye Xue Za Zhi. 2004;25:653-657. 
  51 
 
 
 
 
 
Chapter 4 
 
Retinol and riboflavin supplementation 
decreases the prevalence of anemia in 
Chinese pregnant women taking iron and folic 
Acid supplements 
 
 
                                     Ma AG, Schouten EG, Zhang FZ, Kok FJ, Yang F
, Jiang DC, Sun YY, Han XX. 
 
J Nutr. 2008 Oct;138(10):1946-50. 
 
Chapter 4 
 
 52 
Abstract 
In rural China many pregnant women in their third trimester suffer from anemia (48%) 
and iron deficiency (42%), often with coexisting deficiencies of retinol and riboflavin. 
We investigated the effect of retinol and riboflavin supplementation on top of iron plus 
folic acid on anemia and subjective well being in pregnant women. The study was a 
2-mo double-blind randomized trial. Subjects (n=366) with anemia [Hemoglobin (Hb) 
≤105g/L] were randomly assigned to four groups, all receiving daily 60 mg iron and 
400μg folic acid. The iron+folic acid (IF) group (n=93) served as reference, the 
iron+folic acid+retinol (IFA) (n=91) was treated with 2000 μg retinol, the iron+folic 
acid+riboflavin (IFB) (n=91) with 1.0 mg riboflavin and the iron+folic 
acid+retinol+riboflavin (IFAB) (n=91) with retinol and riboflavin. After the 2-mo 
intervention, the Hb concentration increased in all 4 groups (p<0.001). The increase 
in the IFAB group was 5.4±1.1 g/L greater than in the IF group (p<0.001). The 
reductions in the prevalence of anemia (Hb<110g/L) and iron deficiency anemia were 
significantly greater in the groups supplemented with retinol and /or riboflavin than in 
the IF group. Moreover, gastrointestinal symptoms were less prevalent in the IFA 
group than in the IF group (p<0.05) and improved well being was more prevalent in 
the groups receiving additional retinol and/or riboflavin than in the IF group (p<0.05). 
Thus, a combination of iron, folic acid, retinol and riboflavin was more effective than 
iron plus folic acid alone. Multimicronutrient supplementation may be worthwile for 
pregnant women in rural China. 
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Introduction 
The prevalence of anemia (hemoglobin (Hb) concentration<110g/L) in Chinese 
pregnant women in the third trimester was 48% during 1995-2000 (1), and the 
prevalence of iron deficiency (ID) and iron deficiency anemia (IDA) was 42% and 
19%, respectively (2). Combined iron and folate therapy showed a better therapeutic 
response: the increase in Hb concentrations was 14.2 g/L for women treated with 
both compounds vs 8.0 g/L for those given iron only (3). But overall there are not 
enough data to determine with certainty that routine supplementation with iron alone 
or in combination with folic acid has substantial benefits among populations where 
anemia is common (4). Also deficiencies of vitamins play a role, especially those of 
folate, vitamin A, and riboflavin (5,6). A study in China showed that 35% of pregnant 
women had RBC folate deficiency (7). Therefore, routine supplementation of 400 μg 
folic acid/d should be recommended for pregnant women for preventing neural tube 
defects (8), as well as preterm delivery and low birth weight (9). 
It was reported that there is a low prevalence of parasitic infection in the rural 
population (hookworm, 0.65%; ascaris lumbricoides 5.16%) in recent years, and this 
has been never considered as an important factor of anemia in rural China (10). In 
fact, retinol and riboflavin deficiencies tend to co-exist in anemic pregnant women in 
developing countries or impoverished settings (11). 44% of women were deficient in 
at least one B vitamin (9). Biochemical evidence of riboflavin deficiency was 
documented during the third trimester of pregnancy (12). Serum concentration of 
retinol <0.70 µmol/L is associated with an increased risk of preterm delivery and 
maternal anemia (13). Supplementation with iron and riboflavin enhances dark 
adaptation response to vitamin A-fortified rice in iron-deficient, pregnant, nightblind 
Nepali women (6). Retinol or riboflavin plus iron supplementation could improve 
hematological status better than iron alone (14). In a previous unpublished study in 
2001, we observed that about 55% of pregnant women suffered from anemia, and 
the mean vitamin A intake was only 54% of the Chinese recommended daily 
allowance (RDA). Riboflavin deficiency was widely prevalent among pregnant 
women. This prompted us to perform the present study, with the objective to 
investigate the efficacy of vitamin A and/or riboflavin supplementation on top of iron 
and folic acid on hematologic status, subjective well being and the occurrence of 
possibly iron related gastrointestinal symptoms. 
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Subjects and Methods 
Study design and subjects.  
The study was a 2-mo double-blind randomized trial of retinol and riboflavin on a 
background of iron and folic acid supplementation, in a two-by-two factorial design. It 
was carried out in a rural area of China. A total of 633 pregnant women, 12-24-wk 
gestation, age range 20-35y, were anemic with Hb <110g/L. The cutoff value of 
anemia in pregnant women was later decided to be ≤105g/L in the study; therefore, 
178 pregnant women did not meet the inclusion criteria, and a further 89 women with 
Hb≤105g/L refused to take any “drugs” during pregnancy. Finally, 366 women 
remained [Hb: >80 and ≤105g/L, no dietary supplements during 2 months, no 
abnormal pregnancy response and receiving daily folic acid (400μg)]. They were 
allocated to the four intervention groups in the order of enrollment. Registration 
numbers 1, 5, 9, 13 etc. all were allocated to one group. To the groups the four 
treatments were randomly assigned, leaving the key in a sealed envelope with an 
independent person in the Institute. IF (n=93) as a reference group were 
supplemented with 60 mg iron as ferrous sulfate, IFA (n=91) with 2 mg retinol (as 
retinyl palmitate) and 60 mg iron, IFB (n=91) with 1.0 mg riboflavin and 60 mg iron, 
and IFAB group (n=91) with 2000 μg retinol, 1.0 mg riboflavin and 60 mg iron daily, 
respectively (Figure 4.1). The sample size was calculated based on difference 
between the groups, not on interaction effects. An increase of 3 g/L () in IFA and IFB 
compared with the IF and an additional increase of 3 g/L compared with the IFA and 
the IFB group. Considering a 5% significance level and a power of 0.80, the total 
required number of subjects for the study, was 340 anemic pregnant women (85 
subjects for each group). The capsules were colored in red, yellow, green and blue 
and manufactured by Hurun’ company (a Chinese food-additive company, Beijing). 
Trial participants and the research team were unaware of the treatment assignment. 
The trial was deblinded after the analysis of the primary outcomes. 
After obtaining written consent, the pregnant women had a baseline interview to 
obtain data on dietary habits, alcohol intake, and tobacco use, and information on 
household socioeconomic status. Information on well-being, gastrointestinal side 
effects, appetite and physical functions, were assessed at the end of the treatment 
period by use of the Short Form 36 (SF-36) (15), a self-administered 
questionnairewhich was translated from English to Chinese and used in China(16). 
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During the trial, a village nurse was responsible for recruitment of the subjects and 
the distribution of the supplements. After ascertainment of eligibility, consenting 
women were enrolled in the study to receive their allocated supplements daily for a 
period of two months. Women were home-visited once each week by the village 
nurse to replenish supplements and to monitor compliance by counting and recording 
the number of supplements that were taken. Village nurses provided counseling 
about possible side effects of taking the supplement. The average number of 
capsules taken was 62 in IF, 60 in IFA, 61 in IFB and 62 in IFAB group during the two 
months’ supplementation. 
The study was approved by the ethical review committee of the Medical College of 
Qingdao University. Written consent was given by each subject at the start of the 
trial.  
 
Sample collection and laboratory analyse. 
Samples of blood (5mL) and urine samples (10mL) were collected from subjects, and 
transported on dry-ice and stored frozen at -80 °C until analysis. The baseline and 
final samples were analyzed in duplicate during the same analytic run.  
Plasma retinol concentrations were measured by HPLC (17). Folic acid in plasma 
was measured by radioimmunoassay method. The nutritional status of riboflavin was 
determined by the ratio of urine riboflavin/creatinine, and the erythrocyte glutathione 
reductase activity coefficient (EGRAC) was measured for assessing riboflavin status 
(18). 
Hemoglobin concentration was measured by using HemoCue. Measurements of 
serum ferritin were performed by radioimmunoassay (19), as described by the 
manufacturer (The North Biological.Technology Institute, Beijing, China). The cutoff 
value for mild to moderate anemia was Hb ≤105 g/L in the second and third trimester 
of pregnancy. The erythrocyte protoporphyrin (EP) was measured with a 
hematofluorometer. The sTfR assay was performed using a commercial kit (R&D 
Systems, Minneapolis, MN). According to the instruction of the kit, the central 95th 
percentile of the reference distribution of soluble transferrin receptor (sTfR) 
concentration is 4.0 mg/L to 9.1 mg/L.The cutoff value of iron deficiency was >9.1 
mg/L. All sTfR assays were performed in duplicate. Plasma iron concentrations were 
analyzed by atomic absorption spectrometry on an Analyst 3100 Analyzer (Perkin 
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Elmer Life Sciences, Wellesley, MA). Total iron-binding capacity (TIBC) was 
determined by a turbidimetric method.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.1 The trial profile. 
The study was conducted in Shen’ county with 960 000 population from 2002 to 2005. At the 
start of the enrollment, there were 633 pregnant women with Hb concentration <110g/L. 
However, the cutoff value of Hb ≤105g/L was considered as anemia in the study, and 178 
pregnant women did not meet the inclusion criteria, and 89 women refused to take any 
“drugs” during pregnancy. During the trial, the reasons for subject losses mainly were 
preterm delivery, weakness, moved out of the trial area, drop-out, etc; some subjects did not 
complete all measurements because of insufficient plasma sample volume. Weakness was 
defined as physically too tired to participate, assessed through questionnaire. 
1521 pregnant women screened at 12 to 24 weeks of gestation 
633 women with Hb<110g/L 
366 subjects randomised over four groups, all 
receiving daily 60 mg iron as ferrous sulfate and 
400μg folic acid 
Exclusion criteria (Hb >105g/L and 
<110g/L) (n=178); Declined to 
participate (n=89) 
Reference 
 (IF, n=93) 
Riboflavin  
 (IFB, n=91) 
 
Retinol 
 (IFA, n=91) 
Retinol and 
riboflavin 
 (IFAB, n=91)  
 
5 subjects lost:  
Vomiting, n=3 
Weakness, n=1 
Drop-out, n=1 
5 subjects lost: 
Weakness, n=2  
Delivery, n=2; 
Moved out, n=1 
6 subjects lost: 
Weakness, n=2 
Delivery, n=2 
Drop-out, n=2 
8 subjects lost, 
Weakness, n=2 
Delivery, n=2 
Moved out, n=4 
n=85 n=86 n=88 
 
n=83 
 
n=65 
Volume of blood sufficient for analysis of additional valuables 
 such as plasma sTfR, plasma iron, plasma retinol, etc. 
Hb, ferritin analyzed, well-being and side effects ofsupplemented investigated. 
n=63 n=69 n=56 
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Statistical analysis 
Categorical data are presented as frequencies, such as prevalence of anemia, 
whereas continuous data are presented as means±SD or means±SEM. Baseline 
iron, folate and anemia status of pregnant women were compared across treatment 
groups. The differences in mean change over the intervention period between 
intervention groups and reference group and 95% confidence intervals (CI) were 
estimated for hematologic indicators and vitamin levels using a general linear model 
ANOVA. Prevalence ratios (PR) and 95% CI’s for mild to moderate anemia (Hb 
<105g/L), all anemia (Hb<110g/L) and iron deficiency anemia (IDA, Hb<110g/L and 
ferritin <12µg/L), and for well-being and gastrointestinal symptoms were estimated 
using a binomial model. Since there was no indication of interaction between retinol 
and riboflavin in 2x2 factorial analysis (p=0.702 for Hb, p=0.777 for ferritin, p=0.746 
for sTfR), we calculated variables for each treatment (retinol and riboflavin) using 
one-way ANOVA followed by Bonferroni correction. Therefore, the effects on 
changes in Hb concentration, ferritin and sTfR were then assessed by including them 
in a general linear model. A α of 0.05 was taken as significance level for all tests. 
 
Results 
In the trial, 366 pregnant women with Hb 80-105g/L were enrolled. Of them 342 
finished the trial and supplied blood for the Hb and ferritin analyses. For 89 subjects, 
plasma volumes were insufficient for the measurement of all parameters 
(Figure.4.1). Therefore, statistical analyses for a number of variables were based on 
smaller numbers.  
There were no substantial differences between the groups in age, gestational stage, 
parity, hematological status and vitamin levels at baseline (p>0.05) (Table 4.1). After 
the 2-mo trial, there were significant increases of Hb, plasma ferritin and iron 
concentrations, and decreases in sTfR, EP and TIBC in all four groups (Table 4.2).  
Compared with the reference group, there was a greater increase in Hb 
concentration in the IFA and in the IFAB group (Table 4.1). Moreover, changes in 
plasma iron, EP and TIBC differed significantly between the IFAB group and the 
reference group. Except for a significantly greater decrease in sTfR, the IFA and IFB 
groups did not differ from the IF group (Table 4.1). The changes in plasma folate and 
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retinol, and riboflavin in urine and EGRAC were as expected (Table 4.3). Moreover, 
in the IFAB group, the prevalence of mild to moderate anemia, all anemia and IDA 
were reduced to 7.2%, 15.7% and 6.0%, respectively, significantly lower than in the 
IF group (Table 4.4). Retinol (IFA and IFAB) and riboflavin (IFB and IFAB) treatments 
both increased Hb concentrations (3.62g/L, p<0.01 and 1.78g/L,p<0.05, respectively) 
and decreased sTfR levels compared to no retinol (IF and IFB) or riboflavin (IF and 
IFA) treatment, respectively; the change of ferritin was greater in women treated with 
retinol (IFA and IFAB) than in those that were not (IF and IFB) (p<0.05) (Table 4.5). 
The percentage of people who reported subjective well-being was higher in IFAB, 
IFA, and IFB groups than the IF group (Table 4.6). The percentages of women who 
felt better, less pale and had better appetites, were 75%, 49% and 41% of subjects in 
the IFAB group, and 71%, 46% and 42% in IFB group, respectively, significantly 
higher than in the other groups. In contrast, the percentages of women with 
gastrointestinal symptoms, including nausea, abdominal discomfort, vomiting, were 
much significantly lower in the IFAB (2%), IFB (5%) and IFA (6%) groups than in the 
IF group (21%).  
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Table 4.1 Baseline characteristics of anemic pregnant women according to treatment1 
Items IF
2
 IFA
2
 IFB
2
 IFAB
2
 
Characteristics n
3
  n
3
  n
3
  n
3
  
 Age, y 88 28.1 ± 3.6 86 28.2 ± 3.6 85 28.0 ± 3.7 83 28.1 ± 3.5 
 Gestational age, wk 88 20.9 ± 5.6 86 21.1 ± 5.6 85 20.7 ± 5.4 83 20.7 ± 5.5 
 Parity, n 88  1.3 ± 0. 5 86 1.3 ± 0. 5 85  1.3 ± 0. 4 83 1.3 ± 0. 4 
Indicators 
        
 Hemoglobin, g/L 88 96.6 ± 7.3 86 96.8 ± 6.4 85 96.9 ± 7.1 83 97.0 ± 7.2 
 Plasma Ferritin
3
, μg/L 88 14.9 ± 8.4 86 15.0 ± 6.6 85 14.9 ± 6.1 83 14.9 ± 7.0 
 Plasma sTfR ,mg/L 65 11.9 ± 4.6 63 11.9 ± 4.9 69 12.0 ± 4.3 56 11.9 ± 4.1 
 Plasma iron, μmol/L 65 12.9 ± 1.7 63 12.9 ± 1.9 69 13.0 ± 1.9 56 12.9 ± 2.0 
 EP, µmol/mol heme 65 80.4 ± 83.1 63 82.2 ± 97.7 69 80.4 ± 74.2 56 83.5 ± 63.4 
 Total iron binding capacity, 
μmol/L 
65 67.4 ± 10.5 63 66.9 ± 10.2 69 67.8 ± 9.4 56 65.9 ± 11.2 
 Plasma retinol, μmol/L 65 1.25 ± 1.11 63 1.20 ± 1.11 69  1.19 ± 0.96 56 1.24 ± 0.95 
 Plasma Folic acid, nmol/L 65 8.38 ±3.62 63 8.61 ± 4.30 69 7.93 ± 3.40 56 8.38 ± 3.62 
 Urine Riboflavin, mmol/mol 65 0.22 ± 0.17 63 0.23 ± 0.22 69 0.22 ± 0.20 56 0.21 ± 0.19 
 
1
Values are means ± SD; 
2
 See Figure 4.1 for groups, missing values or insufficient plasma analysis;
3 
Geometric means ± SD. 
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Table 4.2Changes in hematologic indicators in anemic pregnant women during intervention with retinol and riboflavin
1
. 
Indicators Groups
2
 n
2
 Baseline 
Change
 
from baseline 
Difference 
from IF 
P –value 
 for difference 
Hemoglobin, g/L      
 IF 88 96.6 ± 7.3 17.2 ± 1.01* -- - 
 IFA 86 96.8 ± 6.4 21.2 ± 0.97* 3.92 (1.71, 6.13) 0.001 
 IFB 85 96.9 ± 7.1 19.3 ± 1.02* 2.08 (-0.13, 4.30) 0.065 
 IFAB 83 97.0 ± 7.2 22.6 ± 1.07* 5.39 (3.16 7.62) <0.001 
Plasma Ferritin, μg/L      
 IF 88 14.9 ± 8.4 5.6 ± 1.88* -- - 
 IFA 86 15.0 ± 6.6 9.4 ± 1.71* 3.82 (-0.68, 8.40) 0.096 
 IFB  85 14.9 ± 6.1 8.1 ± 1.98* 2.51 (-2.05, 7.06) 0.280 
 IFAB  83 14.9 ± 7.0 11.0 ± 1.68* 5.43 (0.83, 10.02) 0.021 
Plasma sTfR ,mg/L      
 IF 65 11.9 ± 4.6 -3.0 ± 0.63* -- - 
 IFA 63 11.9 ± 4.9 -4.0 ± 0.72* -0.95 (-1.93, 0.02) 0.054 
 IFB  69 12.0 ± 4.3 -4.0 ± 0.59* -0.98 (-1.93, -0.03) 0.043 
 IFAB  56 11.9 ± 4.1 -4.7 ± 0.73* -1.71 (-2.71, -0.70) 0.001 
Plasma iron, μmol/L      
 IF 65 12.9 ± 1.7 5.4 ± 0.61* - - 
 IFA 63 12.9 ± 1.9 6.0 ± 0.55* 0.70 (-0.88, 2.27) 0.384 
 IFB  69 13.0 ± 1.9 6.3 ± 0.56* 0.99 (-0.55, 2.53) 0.207 
 IFAB  56 12.9 ± 2.0 7.8 ± 0.75* 2.41 (0.79, 4.04) 0.004 
EP, µmol/mol heme      
 IF 65 80.4 ± 83.1 -34.3 ± 11.67* - - 
 IFA 63 82.2 ± 97.7 -47.7 ± 12.75* -13.36 (-28.18, 1.45) 0.053 
 IFB  69 80.4 ± 74.2 -41.4 ± 11.32* -7.10 (-22.71, 8.52) 0.293 
 IFAB  56 83.5 ± 63.4 -49.9 ± 9.11* -15.57 (-30.93, -0.20) 0.029 
Total iron binding capacity, μmol/L      
 IF 65 67.4 ± 10.5 -12.0 ± 1.92* - - 
 IFA 63 66.9 ± 10.2 -15.2 ± 1.73* -3.16 (-6.79, 0.47) 0.089 
 IFB  69 67.8 ± 9.4 -13.4 ± 1.83* -1.39 (-5.39, 2.60) 0.442 
 IFAB  56 65.9 ± 11.2 -17.3 ± 1.88* -5.29 (-8.95, -1.63) 0.006 
 
1
 Values are means ± SEM, or means (95% CI). * Significant change from baseline, p<0.05. 
2
 See Figure 4.1 for groups and sample size; values due to missing values or insufficient plasma samples. 
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Table 4.3 Changes in vitamin status in anemic pregnant women during  
intervention with retinoland riboflavin1. 
Indicators Group
2
 n
2
 Baseline 
Change 
from baseline 
Difference 
from IF 
P-value 
for difference 
Plasma retinol, μmol/L    
 IF 65 1.25±1.11 -0.04± 0.15 -- - 
 IFA 63 1.20± 1.11 0.80±0.18* 0.84 (0.58, 1.10) <0.001 
 IFB  69 1.19±0.96 0.02 ± 0.13 0.03 (-0.24, 0.29) 0.840 
 IFAB  56 1.24±0.95 0.85±0.17* 0.89 (0.62, 1.16) <0.001 
Plasma Folic acid, nmol/L    
 IF 65 8.38±3.62 5.32 ±1.79* -- - 
 IFA 63 8.61±4.30 8.09 ±1.47* 1.76 (-1.68, 7.25) 0.220 
 IFB  69 7.93±3.40 6.32±1.34* 1.00 (-3.56, 5.57) 0.667 
 IFAB  56 8.38±3.62 6.50 ±1.34* 1.18 (-3.53, 5.89) 0.624 
Urine Riboflavin, mmol/mol    
 IF 65 0.22±0.17 0.03± 0.03 -- - 
 IFA 63 0.23±0.22 0.01± 0.03 -0.01 (-0.07, 0.04) 0.612 
 IFB  69 0.22±0.20 0.12 ±0.03* 0.09 (0.04, 0.14) <0.001 
 IFAB  56 0.21±0.19 0.13±0.03* 0.10 (0.05, 0.15) <0.001 
EGRAC      
 IF 65 2.06±0.99 -0.17± 0.16 -- - 
 IFA 63 1.89 ± 0.77 -0.22 ±0.14 -0.05 (-0.21, 0.31) 0.698 
 IFB  69 1.90±0.78 -0.71±0.12* -0.54 (-0.81, -0.28) <0.001 
 IFAB  56 1.85±0.76 -0.68±0.13* -0.51 (-0.79, -0.23) <0.001 
 
1
 Values are means ± SEM, or means (95% CI). * Significant change from baseline, p<0.05. 
2
 See Figure 4.1 for groups and sample size; values due to missing values or insufficient  
plasma samples.  
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Table 4.4 Prevalence of anemia in anemic pregnant women after 
Interventionwith retinol and/or riboflavin 
anemia
1
 Groups n
2
 % PR (95% CI)
 3
 
Moderate anemia   
 IF 88 18.2 -- 
 IFA 86 9.3 0.51 (0.10, 0.92)* 
 IFB  85 11.8 0.65 (0.17, 1.12) 
 IFAB  83 7.2 0.39 (0.04, 0.75)* 
All anemia     
 IF 88 29.6 -- 
 IFA 86 18.6 0.63 (0.28, 0.97)* 
 IFB  85 23.5 0.79 (0.40, 1.19) 
 IFAB  83 15.7 0.53 (0.21, 0.84)* 
Iron deficiency anemia  
 IF 88 15.9 -- 
 IFA 86 8.1 0.51 (0.07, 0.95)* 
 IFB  85 10.6 0.67 (0.15, 1.19) 
 IFAB  83 6.0 0.38 (0.01, 0.75)* 
1
Moderate anemia: hemoglobin 80-105g/L; all anemia: Hb<110g/L;  
Iron deficiency anemia: Hb<110g/L and plasma ferritin<12μg/L; 
2
see Figure 4.1  
for groups and sample size; 
3
PR, prevalence ratio; CI, Confidence Interval, are  
calculated using the IF group as the reference.
 
 
 
Table 4.5 Effects of retinol and riboflavin in anemic pregnant women,  
evaluated with factor analysis 
 
1
Retinol treatment including IFA and IFAB groups, n=169 (125 in sTfR);  
2
Riboflavin treatment including IFB and IFAB groups, n=173 (119 in sTfR). 
 
Hematologic 
indicator 
Retinol
1
 riboflavin
2
 
n 
Estimated effects 
(95% CI) 
P 
value 
n 
Estimated effects 
(95% CI) 
P 
value 
Hb,  
(g/L) 
169 3.62 (2.03, 5.20) <0.001 173 1.78 (0.16, 3.40) 0.031 
Plasma Ferritin, 
(μg/L) 
169 3.39 (0.15, 6.63) 0.040 173 2.03 (-1.22, 5.29) 0.220 
Plasma sTfR, 
(mg/L) 
125 -0.80 (-1.50, -0.10) 0.024 119 -0.84 (-1.53, -0.14) 0.019 
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Table 4.6 Prevalence of subjective symptoms in anemic pregnant 
women after retinol and riboflavin intervention 
Item
1
 Group
2
 n
2
 %
3
 PR (95% CI) 
4
 
Feeling better   
 IF 89 50.6 -- 
 IFA 86 62.8 1.24 (0.92, 1.57) 
 IFB  83 71.1 1.40 (1.06, 1.75)* 
 IFAB  83 74.7 1.48 (1.12, 1.83)* 
Less pale   
 IF 89 24.7 - 
 IFA 86 37.2 1.51 (0.82, 2.20) 
 IFB  83 45.8 1.85 (1.05, 2.65)* 
 IFAB  83 49.4 2.00 (1.15, 2.85)* 
Appetite better   
 IF 89 20.2 -- 
 IFA 86 24.4 1.21 (0.54, 1.88) 
 IFB  83 42.2 2.09 (1.08, 3.10)* 
 IFAB  83 41.0 2.03 (1.04, 3.02)* 
Stronger, and other improvements  
 IF 89 27.5 -- 
 IFA 86 39.5 1.44 (0.82, 2.05) 
 IFB  83 33.7 1.23 (0.67, 1.78) 
 IFAB  83 38.6 1.40 (0.80, 2.01) 
GI side effects (such as vomiting, nausea, abdominal discomfort) 
 IF 89 21.4 -- 
 IFA 86 5.8 0.27 (0.02, 0.53)* 
 IFB  83 4.8 0.22 (0.01, 0.46) 
 IFAB  83 2.4 0.11 (0.05, 0.27) 
 
1
Well being, including feeling better, less pale (self-reported by subjects who often see 
themselves in mirror), appetite better, stronger and other improvements as physical 
functions, such as doing housework, farm-work, walking, etc; GI: Gastrointestinal; 
gastrointestinalside effects: including nausea, abdominal discomfort, vomiting, etc. 
2
See 
Figure 4.1 for groups and sample size. 
3 
Proportions of well being or side-effects in four 
groups.  
4
PR, prevalence ratio; CI, confidence Intervals; PR and 95% CI are calculated 
using the IF group as the reference; *significant change from baseline, p<0.05.
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Discussion 
During the trial all four groups of pregnant women with anemia significantly improved 
in Hb concentration and anemia prevalence. The increase in Hb concentration in the 
IFAB group was 5.4 g/L greater (p<0.001) compared with in the IF group. This way 
the residual prevalence of anemia after supplementation with iron and folic acid was 
halved by adding retinol and riboflavin. Moreover, gastrointestinal symptoms were 
less prevalent and improved well being was more prevalent in the intervention groups 
than in the reference group. 
Compared with the few similar studies carried out so far (14, 20), ours had a 
relatively large study population. It was carried out under difficult circumstances in a 
poor rural part of China, where nutritional problems, especially among pregnant 
women are frequent. However, compliance was excellent because study subjects 
were motivated by the offer of free of charge medical care, and all women were 
weekly visited by village nurses, who counted left-over capsules, provided new 
supplies and gave support in case of any problems or questions related to the study. 
Unfortunately, there was a small proportion (6.6%) of women who dropped out after 
randomization. This drop out and the underlying reasons were evenly distributed over 
the groups. Due to restriction to the amount of blood that we were allowed to draw 
we had missing data on a number of hematologic variables for about 80 participants. 
These were reasonably evenly distributed over the groups and the remaining groups 
were still balanced with respect to important characteristics.  
The quality of the supplements was assured by storage at -20 0C and micronutrient 
levels were examined every three months, showing no appreciable changes. 
Although the four treatment capsules had different colors, blinding of both 
participants and study personnel stayed intact, since there was no need to break the 
code before the main analyses had been carried out. In our trial, most subjects only 
knew their own supplement which was provided by their village nurse. Since they 
lived in a remote area, contacts with other trial participants were rare. 
Riboflavin deficiency may be one of the most common vitamin deficiencies in 
regions, like rural areas in China, where diets are predominantly rice-based and 
contain insufficient milk, meat, fish, fresh fruit or vegetables (21). The riboflavin 
combined with iron was also considered to be beneficial to anemic pregnant women 
(14) and significantly reduced the prevalence of riboflavin deficiency and iron 
deficiency anemia (6). Our results further confirmed the positive effect of the 
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combination of retinol and riboflavin on anemia in Chinese pregnant women from 
rural areas (22, 23). 
We found evidence for an additive effect of retinol and riboflavin on hematologic 
parameters and anemia on top of iron and folic acid. This may be explained by the 
co-existing deficiencies of these micronutrients in our population. The effects of 
retinol and riboflavin appeared to be additive and we did not find evidence for 
interaction. This may indicate that the beneficial effects of each of the vitamins on 
erythropoiesis are independent. It is well known that retinol plays an important role in 
reducing anemia and improving iron status. Retinol enhances iron utilization by 
stimulating erythropoiesis and iron metabolism by raising mean red cell volume, 
plasma Fe concentration and total Fe-binding capacity (23,24). Improvement of poor 
appetite was observed in 42.2% and 41.0% of the IFB group and IFAB group, 
respectively. Riboflavin is thought to improve iron uptake and absorption by 
improving the gastrointestinal function (25) and better appetite, which may have 
resulted in significantly enhanced concentration of serum iron (26). Consistently, 
women who took riboflavin had better appetites (subjectively) than those who did not 
take any riboflavin. At the same time, riboflavin is also necessary for synthesis of the 
globin component of hemoglobin (27). 
In our study, the combination of iron and folic acid had already a strong beneficial 
effect and the study was designed to demonstrate possible additional efficacy of 
retinol and/or riboflavin. Such additional benefits are expected to be modest.  
In conclusion, these women often show poor nutritional status, lacking sufficient 
dietary intake of multiple micronutrients. Surprisingly, almost none of the subjects 
took dietary supplements, including iron. Our study showing additional benefits of 
vitamins in tackling the anemia problem has important public health implications. It 
underlines the need for a comprehensive nutritional policy for this target population. 
Besides improving their diet, multimicronutrient supplementation may be worthwile for 
pregnant women in rural China.  
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ABSTRACT 
Pregnancy is a condition exhibiting increased susceptibility to oxidative stress and 
iron plays a central role in generating harmful oxygen species. The objective of this 
study is to investigate change in hematological status, oxidative stress and 
erythrocyte membrane fluidity in anemic pregnant women after iron with and without 
combined vitamin supplementation. The study was a 2 months double-blind 
randomized trial. Pregnant women (n=164) were allocated to four groups: C:  
placebo; I: daily 60 mg iron (ferrous sulfate); IF: in addition 400μg folic acid; IM: in 
addition 2 mg retinol and 1 mg riboflavin, respectively. After the 2-months’ trial, 
Hemoglobin (Hb) significantly increased with15.8, 17.3 and 21.8 g/L , and ferritin with 
2.8, 3.6 and 11.0μg /L in the I, IF and IM groups compared with placebo. Polarisation 
(ρ) and microviscosity (η) decreased significantly in comparison with placebo, 
indicating increase in membrane fluidity. Significant decreases of ρ and η values 
compared with C were 0.033 and 0.959 for I, 0.037 and 1.074 for IF, and 0.064 and 
1.865 for IM, respectively. In addition, significant increases of glutathione peroxidase 
activities and decreases of malondialdehyde were shown in all treated groups, as 
well as increases of plasma retinol and urine riboflavin in IM. The findings show that 
supplementation with iron and particularly in combination with vitamins could improve 
hematologic status as well as oxidative stress and erythrocyte membrane fluidity. 
 
 
 
 
 
 
 
 
 
Iron combined vitamins improves haematological, erythrocyte, oxidative stress 
 
 71 
Introduction 
Iron is an essential trace element that is frequently deficient in infants and in women 
of reproductive age from developing countries. Prevalence of anemia is still high in 
rural areas in China(1). Iron deficiency is associated with anemia(2), and impairment of 
iron-dependent enzymes and proteins(3).Iron supplementation is almost universally 
recommended during pregnancy to correct or prevent deficiency(4). However, 
pathological accumulation of the metal within tissues aggravates the generation of 
reactive oxygen species (ROS) and elicits toxic effects, which are mainly related to 
oxidative stress(5). Iron plays a central role in generating harmful oxygen species. Its 
redox cycling promotes the Fenton reaction producing the potent oxidant hydroxyl 
radical(6). ROS can alter the chemical and physical properties of cell membranes 
leading to a structural alteration, which could modify membrane activity and cause a 
reduction in membrane fluidity that can be assessed in the erythrocyte(7). Several 
studies have reported that free radicals are relatively low in normal conditions due to 
active defense systems, including chemical scavengers or antioxidant molecules, 
superoxide dismutase (SOD), and glutathione peroxidase (GSH-Px). In rats, both 
iron deficiency and excess result in free radical mitochondrial damage(8). The 
excessive superoxide produced by abnormal redox reactions can also cause 
biochemical modification of red blood cell (RBC) membrane protein. This would result 
in changes of membrane structure or trans-membrane transport and exert a variety of 
cytotoxic effects(9), and would affect membrane viscoelasticity. 
In relation to pregnancy, there was a report that supplementation with vitamin C 
(1000 mg/d) and vitamin E (400 mg/d) might be beneficial in pregnant women with 
increased risk of preecclampsia, a complication in which oxidation is an important 
feature(10). Two large randomized trials showed, however, that supplementation with 
vitamin C and E during the second trimester did not reduce the risk(11,12). The 
administration of an iron supplement with vitamin C to 27 women during the third 
trimester of pregnancy significantly increased maternal iron status as well as an 
indicator of lipid peroxidation, compared with controls(13). Increased oxidative stress 
was reported to occur in uncomplicated pregnancy and to be counteracted by a high 
level of plasma vitamin E(14). 
Thus, provision of a moderate dose of iron (100mg/d) might be deleterious in certain 
and not in other circumstances with respect to the possible generation of oxy-free 
radicals. Therefore, the purpose of the study was to investigate the effect of 
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supplementation with iron only, and iron combined with folic acid or with folic acid, 
retinol and riboflavin, on hemotological status, oxidative stress parameters, such as 
SOD, GSH-Px and malondialdehyde (MDA) level, and erythrocyte membrane fluidity 
in anemic pregnant women during the trial.  
 
Materials and Methods 
Participants 
The study was a 2 months intervention trial of the effect of 1) iron, 2) iron and folic 
acid, and 3) iron, folic acid, retinol and riboflavin on indicators of oxidative stress, 
compared with placebo. Participants were recruited between March 2004 and 
September 2006 from the community hospitals of Shen’s county in the central area of 
China. 366 pregnant women consented to participate and fulfilled the other eligibility 
criteria of no dietary supplements during the past 2 months and no abnormal 
pregnancy response. Finally, a random sample of 164 anemic pregnant women 
(80g/L< Hb <110 g/L), 12 to 24 weeks gestation, and 20 - 35 years old, were 
randomly allocated to four groups in the order of recruitment: group C (n=41) was the 
placebo control group, group I (n=41) was supplemented daily with 60 mg iron as 
ferrous sulfate, IF (n=41) with 60 mg iron and 400μg folic acid, IM (n=41) with 60 mg 
iron, 400μg folic acid, 2 mg retinol and 1 mg riboflavin. The sample size was 
calculated based on a difference in hemoglobin (Hb) change (δ) of 5 g/L between the 
intervention groups and placebo and a standard error of 6.67 g /L was derived from 
the study reported by Suharno(15). Considering a 5% (=0.05) significance level and 
a power of 0.80 (=0.20), the total number of subjects required for the study was 164. 
Treatments were blindly assigned to the groups, leaving the key in a sealed envelope 
with an independent person in the Institute. The capsules were labelled in red, 
yellow, green and blue color and manufactured by Hurun company (a Chinese food-
additives company, Beijing, China). Trial participants and the research team were 
unaware of the treatment assignment. The trial was deblinded after analysis of the 
primary outcomes. 
Pregnant women were enrolled after obtaining written informed consent and had a 
baseline interview on characteristics, such as age, gestation, previous pregnancies, 
etc. In each community, a local female community health worker called “village 
nurse”, was responsible for recruitment and distribution of the supplements. After 
ascertainment of eligibility, consenting women were enrolled in the study, had a 
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baseline interview and started with their allocated supplements to be taken daily for a 
period of two months. Women were home-visited once each week by the village 
nurse to replenish supplements and to monitor compliance by counting and recording 
the number of supplements that were taken. The nurse also provided counseling 
about possible side effects. 
This study was conducted according to the guidelines laid down in the Declaration of 
Helsinki and all procedures involving human subjects were approved by the ethics 
committee of Medical College of Qingdao University (QY-ETC2002821).  
 
Sample collection and laboratory analyses 
Before and at the end of the intervention overnight fasting (>12h) blood samples 
were collected between 6 and 8 am. Moreover, daily sample collection was evenly 
distributed over each of the four groups. The urine first pass was discarded and the 
next 10ml was collected in dark containers for riboflavin and creatinine analysis, 
which were immediately aliquoted. The samples were transported on dry-ice and 
stored frozen at -80 °C until analysis. The baseline and final samples were analyzed 
in duplicate during the same analytic run.  
Plasma retinol concentrations were measured by reversed-phase high-performance 
liquid chromatography (HPLC) (Beckman 5000 with detector of 168, USA) and the 
within-assay and between assay CVs were 3% and 8%, respectively(16). Folic acid in 
plasma was measured by radioimmunoassay method. The nutritional status of 
riboflavin was determined by the ratio of urine riboflavin/creatinine (Cr) (17).  
Hemoglobin concentration was measured by the cyanomethemoglobin method by 
using HemoCue for confirmation. The cutoff value of anemia was Hb<110g/L.  
Measurements of serum ferritin were performed by radioimmunoassay(18), as 
described by the manufacturer (The North Biological.Technology Institute, Beijing, 
China). Plasma iron concentrations were analyzed by atomic absorption 
spectrometry on an Analyst 3100 Analyzer (Perkin Elmer Life Sciences, Wellesley, 
MA).  
The activities of superoxide dismutase (SOD), glutathione peroxidase (GSH-Px) were 
determined in plasma(19) as U/ml and IU/ml, respectively. The MDA concentration 
was determined by using the thiobarbituric acid reaction, and calculated by 
comparing the absorbance values of the samples with those of standard MDA 
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solutions. Results were expressed as nmol/ml blood. Additionally, routine parameters 
were also studied in plasma from the subjects(20). 
The erythrocyte membrane fluidity can be measured by fluorescence polarization (ρ) 
and microviscosity (η). To evaluate membrane fluidity by fluorescence spectroscopy, 
cell suspensions were incubated with the fluorescence probes (final concentration 
10−6 M). Erythrocytes were washed by the physiological saline, and suspended in the 
phosphate buffered saline (PBS) solution (pH = 7.4) at 0.01mol/L. To the 
erythrocytes suspension, 1,6-diphenyl-1,3,5-hexatriene (DPH, 2 x10-6 mol/L) was 
added before being incubated in a water bath at 250C for 15 min(21). Samples were 
illuminated with the linear (vertically – v or horizontally – h) polarized monochromatic 
light (λex) and the emitted fluorescence intensities (I - in arbitrary units) parallel or 
perpendicular to the direction of the excitation beam were recorded. The suspension 
was examined by spectrofluorophotometer (Perkin Elmer fluorescence spectrometer, 
LS-50) with the excitation wavelength of 320 nm and emission wavelength of 430 
nm(22,23), ρ and η of the erythrocyte membrane was calculated by the following 
formulae:  
ρ=IVV-GIVH/IVV+GIVH; η=2ρ/0.46-ρ 
Indices V and H denote the vertical and horizontal position of the polarizer in the 
excitation and the fluorescence beam, respectively. G is an instrumental correction 
factor equal to (IVV/IVH), The subscript H refers to the horizontally polarized excitation 
beam. IVV and IVH represent the components of the corrected polarized emission 
parallel and perpendicular to vertical direction, respectively(24,25). 
 
Statistical analysis  
Categorical data are presented as frequencies, such as prevalence of anemia, 
Continuous data, hematologic indicators, vitamin concentrations and oxidative 
parameters, microviscosity and polarization values, were normally distributed and 
presented as mean ± SD. Baseline variables were compared across treatment 
groups using a general linear model ANOVA. Mean changes over the intervention 
period and differences between groups were tested with Student t-tests for 
hematologic indicators, vitamin levels, oxidative indicators and microviscosity and 
polarization values. A two-sided p<0.05 was considered as the significant level for all 
tests.  
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Results 
Complete data were available for 145 of the original 164 pregnant women. 19 women 
did not complete the trial for the following reasons: moved to other villages 5; 
stopped taking supplements 11; not willing to provide a second blood sample 3. 
There were no substantial differences between the remaining groups in any of the 
baseline characteristics (Fig 5.1 and Table 5.1). Compared with the means of 
hematologic status at the start of the trial, significant decreases of Hb, plasma iron 
and ferritin values were found in the placebo group two months later; while the levels 
of hematologic status were significantly increased in the I, IF and IM groups after two 
months supplementation (Fig 5.2.). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
164 anemic pregnant women screened  
at 12 to 24 weeks of gestation 
placebo 
 (n=41) 
Iron, folic acid 
(n=41) 
Iron   
(n=41) 
Iron, folic acid, 
retinol and 
riboflavin  
(n=41)  
 
total lost: 
none 
total lost: 6 
stop treatment: 5 
moved out: 1 
total lost: 7 
stop treatment: 3 
lack of blood: 2 
moved out: 2 
total lost: 6, 
stop treatment: 3 
lack of blood: 1 
moved out: 2 
Analyzed  
(n=34) 
Analyzed 
(n=35) 
Analyzed 
 (n=41) 
Analyzed 
 (n=35) 
2 months trial, home visit once week 
Figure 5.1 The trial profile. The trial enrollment was conducted from 2004 to 2006. Of a 
total of 366 women were eligible, whom we took a random sample of 164, and they were 
allocated to the intervention groups by order of randomization. In the intervention study, 
complete data were available on 145, which is 88.4% of the original number of 164 
pregnant women. 19 women did not complete the trial. However, there were no substantial 
differences between the groups in any of the baseline characteristics. 
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After the 2-months supplementation, there were considerable increases in 
hematologic indicators in I, IF and IM groups compared with C: 15.8 g/L, 17.3 g/L and 
21.8 g/L for Hb (all p values <0.001); 4.7 μmol/L, 5.5 μmol/L and 9.7μmol/L for 
plasma iron (all p values <0.001), and 2.8 μg/L, 3.6 μg/L and 11.0μg/L for ferritin (all 
p values <0.001). The increases of plasma retinol and urine riboflavin in IM were 
26.75μg /dL (p<0.001) and 61.59 mg/g creatinine (p<0.001), respectively. For plasma 
folic acid the increase was 4.06μg/L in the IF group (P<0.001) and 4.65μg/L in the IM 
group (P<0.001), all compared with C (Table 5.2). The increases in all hematologic 
and vitamin indicators in IM were significantly greater than in I (all p values <0.001). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 5.2 A comparison of hematologic status between before and after the trial. The 
blank bars represent the mean and standard deviation of hemoglobin concentration 
(Hb), the square bars for plasma iron concentration and the dot bars for ferritin with 
significant changes between groups; group C as placebo, group I supplemented daily 
with 60 mg iron, IF with 60 mg iron and 400 μg folic acid and IM with 60 mg iron, 400 μg 
folic acid, 2 mg retinol and 1 mg riboflavin, respectively. * Mean value was significantly 
different from that of the control group (p<0.05).  
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Erythrocyte membrane fluidity was evaluated using fluorescence polarization (ρ) and 
microviscosity (η); lower values indicate better membrane fluidity. After the trial, the ρ 
and η values compared with C decreased by 0.033 and 0.959 for I, 0.037 and 1.074 
for IF, and 0.064 and 1.865 for IM, respectively. The ρ and η values in the IM 
compared with those in the I group decreased by 0.031 and 0.906 (all p values 
<0.05), (Table 5.3).  
The changes in oxidative stress parameters are presented in Table 5.3. Compared 
with the C, increases of GSH-Px activities were 37.7, 43.4 and 87.9 IU/ml in the I, IF 
and IM groups, respectively; the levels of MDA decreased by 0.55, 1.06 and 
2.56μmol/L.. Moreover, the increase of GSH-Px activity and decease of MDA level 
were 50.2 IU/ml and 2.01 μmol/L greater in the IM group compared with the I group 
(all p values <0.01); however, there were no important changes of SOD activities 
during the trial.  
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Table 5.1 Baseline characteristics of Chinese anemic pregnant women in four groups§ 
Characteristics 
All baseline C I IF IM 
F P
*
 
Mean SD Mean SD Mean SD Mean SD Mean SD 
Subjects (n) 145 41 35 34 35   
Age (years) 27.4 3.4 27.3 3.4 27.8 3.5 27.4 3.1 27.0 3.7 0.62 0.601 
Gravidity (n) 1.3 0.4 1.3 0.5 1.3 0.5 1.3 0.4 1.2 0.4 0.86 0.464 
Gestational stage (wk) 20.9 4.7 21.1 4.8 21.9 4.4 20.0 4.8 20.3 4.5 1.28 0.285 
Hb (g/L) 99.8 6.5 101.7 8.7 99.5 5.6 99.0 4.8 98.8 5.7 0.76 0.519 
Plasma iron (μmol/L) 12.2 2.1 12.8 2.8 11.6 2.3 11.7 1.5 12.3 1.2 1.88 0.136 
Ferritin (μg/L) 12.1 3.8 12.6 5.1 12.8 2.6 11.9 3.3 10.9 3.6 0.76 0.521 
Folate (μg/L) 3.90 1.84 4.10 1.86 3.68 1.65 4.13 1.95 3.66 1.92 0.21 0.891 
Retinol (μg/dL) 29.68 6.75 30.69 7.95 30.13 6.22 29.78 6.13 27.93 6.20 0.28 0.842 
Riboflavin (mg/g creatinine) 41.95 15.39 42.29 17.64 42.98 14.10 42.52 14.75 39.96 14.90 0.08 0.969 
MDA(μmol/L) 4.97 1.34 4.95 1.10 5.38 1.77 4.68 1.11 4.88 1.28 1.57 0.200 
SOD (U/ml) 73.3 26.2 73.3 35.1 72.3 22.4 73.8 23.3 73.7 20.7 0.02 0.995 
GSH-px (IU/ml) 116.6 29.0 108.3 26.7 116.3 27.1 124.2 30.7 119.4 30.2 2.06 0.108 
 
§
group C: placebo, group I: 60 mg ferrous sulfate; group IF in addition 400 μg folic acid; group IM in addition 2 mg retinol and 1 mg riboflavin.  
*One-way ANOVA. 
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Table 5.2 Comparison of hematologic and vitamin status between  
control and supplemented groups after the trial§ 
 
§
group C: placebo, group I: 60 mg ferrous sulfate; group IF in addition 400 μg folic acid; group IM in addition 2 mg 
retinol and 1 mg riboflavin.*One-way ANOVA.
a,b,c,d
 Mean values within a row with unlike superscript letters were 
significantly different (p<0·05; independent t-test). 
 
 
Table 5.3 Comparison of membrane fluidity and oxidative stress status between  
control and supplemented groups after the trial§ 
 
§
group C: placebo, group I: 60 mg ferrous sulfate; group IF in addition 400 μg folic acid; group IM in addition 2 mg 
retinol and 1 mg riboflavin.*One-way ANOVA.
a,b,c,d
 Mean values within a row with unlike superscript letters were 
significantly different (p<0·05; independent t-test). 
 
 
Indicators 
C I IF IM 
F P* 
Mean SD Mean SD Mean SD Mean SD 
Subjects (n) 41 35 34 35   
Hb (g/L) 99.0 
a
 5.5 114.8
b
 8.6 116.3
c
 6.0 120.8
d
 6.1 80.38 0.000 
Plasma iron 
(μmol/L) 
11.6 
a
 1.9 16.3
 b
 0.5 17.1
 c
 0.8 21.3
 d
 1.5 344.95 0.000 
Ferritin (μg/L) 11.4 
a
 3.4 14.2
 b
 1.2 15.0
 c
 2.2 22.4
 d
 6.4 55.14 0.000 
Folic acid 
(μg/L) 
3.52 
a
 1.50 4.12 1.29 7.58
 c
 1.67 8.17
 d
 1.74 83.44 0.000 
Retinol (μg/dL) 29.05 
a
 6.34 31.31 5.58 31.48 4.93 55.79 
d
 9.00 129.68 0.000 
Riboflavin 
(mg/g creatinine 
ratio) 
39.79 
a
 15.56 47.17 20.03 47.05 19.16 101.38
 d
 46.40 37.91 0.000 
Indicators 
C I IF IM 
F P* 
Mean SD Mean SD Mean SD Mean SD 
Subjects (n) 41 35 34 35   
Membrane fluidity          
  ρ 0.330 
a
 0.052 0.297
 b
 0.012 0.293
 c
 0.008 0.266
 d
 0.009 30.81 0.000 
  η 4.593
 a
 2.088 3.634
 b
 0.419 3.519
 c
 0.243 2.728
 d
 0.178 17.12 0.000 
Oxidative stress          
  GSH-Px (IU/ml) 115.1
 a
 23.5 152.8
 b
 60.0 158.5
 c
 63.8 203.0
 d
 88.5 12.62 0.000 
  SOD (U/ml) 72.5 35.9 76.0 19.6 75.1 17.7 72.9 18.3 0.17 0.915 
  MDA (μmol/L) 5.04
 a
 1.12 4.49
 b
 0.57 3.98
 c
 0.60 2.48
 d
 0.46 78.34 0.000 
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Discussion 
After 2 months supplementation with iron and/or vitamins, anemic pregnant women 
significantly improved in erythrocyte membrane fluidity and antioxidative markers, in 
addition to increases of hemoglobin concentration, plasma iron, ferritin, retinol and 
urine riboflavin concentrations. Most effects were greatest in the iron combined with 
multivitamin (IM) group.  
Up to now, few studies evaluated changes of both hematologic status and 
erythrocyte membrane fluidity after iron supplementation in anemic pregnant women, 
possibly because erythrocyte membrane preparation is quite laborious. Our study 
had a relatively large study population and it was carried out under difficult 
circumstances in a poor rural part of China. Unfortunately, there were a small 
proportion of women who dropped out after treatment allocation, only in the 
supplement groups. Some subjects stopped treatment because of possible side 
effects, including nausea, abdominal discomfort, vomiting(26). For other subjects data 
were not complete because of an insufficient amount of plasma, refusing to give a 
second blood sample or moving out of the area. This did not result in imbalances with 
respect to important baseline characteristics. Compliance of the remaining 
participants was almost complete, probably because study subjects were motivated 
by the offer of free of charge medical care, and by weekly visits by village nurses. 
In fact, retinol and riboflavin deficiencies tend to coexist in anemic pregnant women 
in developing countries or impoverished settings(27). In a previous study (1), high 
percentages of subnormal vitamin A and subnormal riboflavin were 23% and 38% in 
anemic pregnant women. Vitamin A deficiency may also result in anemia in humans 
and animals that can be reversed only by vitamin A supplementation(28). Biochemical 
evidence of riboflavin deficiency was documented during the third trimester of 
pregnancy(29). Retinol or riboflavin plus iron supplementation could improve 
hematological status better than iron alone(30). The reduced prevalence of anemia 
(Hb<110g/L) and ID anemia were significantly greater in the groups supplemented 
with retinol and /or riboflavin than in the iron group. Retinol status is a putative factor 
for improved iron status or iron absorption. Vitamin A and β-carotene may form a 
complex with iron, keeping it soluble in the intestinal lumen as well as preventing the 
inhibitory factors on iron absorption(31). Moreover, gastrointestinal symptoms were 
less prevalent in the group supplemented with iron, folic acid and retinol than in the 
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iron group, and improved well-being was more prevalent in the groups receiving 
additional retinol and/or riboflavin than in the iron group.  
Although fluorescence polarization was used to assess membrane fluidity in past 
decades, now it is frequently applied in oxidative stress(32), erythrocyte 
aggregation(33), understanding of membrane protein function(34), etc. Especially the 
noninvasiveness of the method makes it suitable for clinical applications(35). 
Pregnancy is a condition exhibiting increased susceptibility to oxidative stress. In 
normal pregnancy, the implantation process, proliferation, differentiation, and 
trophoblast invasion, produce reactive oxygen species(36,37). Transitional metals, 
especially iron, which are particularly abundant in the placenta, are important in the 
production of these free radicals(38). Increased iron levels may be responsible for 
placental oxidative stress and abnormalities in antioxidants(39). Iron overload could 
promote the generation of free radicals and result in cellular damage(12), and iron 
supplementation with 100mg/d or overload might be potential risk to increase MDA 
levels or oxidative stress in the maternal plasma and the placenta during 
pregnancy(40). But low doses of oral ferrous iron (36mg/d) did not unfavorably change 
the physiological pattern of parameters of oxidation(41). However, in our stduy, 
hemotological status has been improved and MDA levels decreased in anemic 
pregnant women after iron supplementation daily with 60 mg iron, which might be 
attributed to the favorate supplementation with low dose of iron and a combination of 
three vitamins. Erythrocyte membrane fluidity improved as well, which indicates that 
the iron supplementation did not deteriorate, but even improved antioxidant capacity. 
There are no documented side effects of iron supplements below 100 mg/day(42). Iron 
combined with multivitamin supplementation showed a more favorable effect than 
iron only in our study, and this dose of iron supplementation did not increase 
hemoglobin higher than the optimal concentration needed for oxygen delivery(43). 
Daily supplementation of 100mg iron as ferrous sulfate was recommended during the 
second half of pregnancy to address the corresponding iron requirements(2), and 
risks associated with oxidative stress were not observed in women supplemented 
with 120mg iron once or twice per week(38). Suggested guidelines are ferritin 
<30μg/L: 80-100mg ferrous iron daily, for which there are no documented side 
effects(42).  
Several studies have shown that micronutrient supplementation improves the 
glutathione peroxidase (GSH-Px) activities and decreases levels of 
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malondialdehyde(MDA)(44,20), and antioxidant supplementation was associated with 
better maternal and perinatal outcome in pregnant women with low antioxidant status 
than supplementation with iron and folate alone(45). However, we did not find any 
change of SOD activity during the trial. Some studies showed similar results(46) and 
even a decrease of SOD activity after antioxidant supplementation(47). This aspect 
deserves further study. In our study, antioxidant defenses and oxidative stress 
appear to be favorably modulated by iron supplementation alone. Such findings have 
not been reported in anemic pregnant women before, and further mechanistic studies 
are to be expected.  
Taken together, subjects had more antioxidative capacity, i.e. lower levels of 
circulating lipid peroxidation products (MDA), and higher GSH-Px activity and higher 
vitamin concentrations after 2 months of supplementation. The improvement of 
erythrocyte membrane fluidity, as apparent in decreases of polarization (ρ) and 
microviscosity (η), indicates that the RBCs accumulate less oxidative lesions. 
Moreover, the increase in the plasma antioxidant status could contribute to the 
prevention of polyunsaturated fatty acid peroxidation of erythrocytes. This evidence 
could also explain the lower peroxidation found in subjects supplemented with iron 
and vitamins in comparison with the control. Iron combined with multivitamin 
supplementation showed a more favorable effect than iron only. We could not find 
any indication of an increase of oxidative stress after iron supplementation. On the 
contrary, a moderate dose of iron, preferably combined with multivitamin 
supplementation may be beneficial both by improving anemia and decreasing the 
status of oxidative stress during pregnancy. 
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Abstract 
Background: Iron is an important element for our well being, to prevent or treat 
anemia, and is a cofactor of many enzymes in the antioxidant process. The effect of 
sodium iron ethylenediaminetetraacetate (NaFeEDTA) and ferrous sulfate on iron 
bioavailability and oxidative stress in anemic pregnant women was evaluated. 
Methods: The study was designed as a 2 month randomized controlled trial. 153 
anemic pregnant women, with 80≤Hb<110g/L, were randomly allocated to three 
groups: group C (n=51) was the placebo control group, group I (n=51) was 
supplemented daily with 60 mg iron as ferrous sulfate, IE (n=51) with 60 mg iron as 
NaFeEDTA. Samples of blood were collected from subjects before and at the end of 
the intervention for measurements of hematological indices and oxidative stress 
parameters. Results: After the trial, considerable increases of hematologic indicators 
were: 20.5 g/L and 21.8 g/L for Hb (bothp values <0.001); 4.81 μmol/L and 7.19 
μmol/L for plasma iron (bothp values <0.001), 2.63μg/L and 8.99μg/L for ferritin (both 
p values <0.05) in I and IE groups, respectively, compared with the control group. 
Glutathione peroxidise (GSH-Px) activities increased by 32.6 IU/ml and 75.3 IU/ml, 
and malondialdehyde (MDA) levels decreased by 0.70μmol/L and 1.12μmol/L in I and 
IE groups than in the C (all p values <0.05); moreover, differences of plasma iron, 
ferritin and GSH-Px activity were 2.38 μmol/L, 6.36μg /L and 42.7 IU/ml also 
significantly greater in IE than in I group. Conclusions: Moderate iron 
supplementation may be beneficial to improving iron deficiency and oxidative stress, 
and NaFeEDTA is better than ferrous sulfate. 
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INTRODUCTION 
Iron deficiency is the most common and widespread nutritional deficiency in the 
world1. Prevalence of anemia is still high in rural areas in China 2. The main causative 
factors are poor iron content, low bioavailability of iron, or both in the largely plant-
based diets that are typically consumed in many low-income countries3,4. Therefore, 
administration of iron supplements may be indicated if iron stores are inappropriately 
low at the start of pregnancy or impairment of the expected increase in hemoglobin 
mass in the mother is to be avoided5. 
Ferrous iron, such as ferrous sulfate (FeSO4) and sodium iron ethylenediamine- 
tetraacetate (NaFeEDTA) as two forms of iron supplements, is mostly used for 
correction of iron deficiency. FeSO4, such as inorganic iron has been used to cure 
anemia since 1831. Its absorptivity is very good but it is irritating to the stomach, 
causing gastrointestinal side effects, such as upper abdominal discomfort, nausea, 
and constipation 6,7. NaFeEDTA is an iron chelate that has been used successfully as 
a dietary fortifier in several trials in the developing world8-10, as in this form, the iron is 
protected from inhibitors of iron absorption.  
 It has a bioavailability 2~ 4 times that of ferrous sulfate, especially in meals with high 
phytate content11. Therefore, the study will be expected effectively to improve both of 
iron deficiency and gastrointestinal side effects for iron supplementation in anemic 
pregnant women.  
Pregnancy is a condition exhibiting increased susceptibility to oxidative stress, 
with both mothers and babies being exposed to oxidative stress during and after 
delivery 12. Oxidative stress and damage have also been found in iron deficiency; 
however, increased MDA levels in the maternal plasma and the placenta in the iron-
supplemented group suggests that iron supplementation may contribute to increased 
oxidative stress in women taking iron supplements during pregnancy 13. 
Thus, pregnant women have a higher iron requirement, pregnancy or iron 
deficiency is a condition exhibiting increased susceptibility to oxidative stress and 
iron might play a role in generating harmful oxygen species. Therefore, the objective 
was to investigate the effect of iron supplements on hematological status and 
indicators of antioxidant status such as superoxide dismutase (SOD), glutathione 
peroxidase (GSH-Px) and malondialdehyde (MDA) levels in anemic pregnant women 
during the second and third trimester of pregnancy. It was hypothesized that 
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NaFeEDTA would be better than ferrous sulfate at improving iron status and reducing 
oxidative stress 
 
SUBJECTS AND METHODS 
Subjects 
The study was a 2 month double-blind randomized trial. Participants were 
recruited between June 2003 and December 2005 from the communities of Shen 
county, Shandong province, China. At the start, pregnant women, 12 to 24 -wk 
gestation, age range 20 - 30 y, were examined for eligibility. Finally, 153 anemic 
pregnant women with 80≤Hb<110 g/L, no dietary supplements during the previous 2 
months and no abnormal pregnancy response, were allocated to the three groups in 
the order of enrollment. Group C (n=51) was the placebo control group, group I 
(n=51) was supplemented daily with 60 mg iron as ferrous sulfate, group IE (n=51) 
with 60 mg iron as NaFeEDTA. The capsules were labeled in red, yellow and blue 
color and manufactured by Hurun’s company (a Chinese food-additive company, 
Beijing). Trial participants and the research team were unaware of the treatment 
assignment. The trial was deblinded after analysis of the primary outcomes. 
    After ascertainment of eligibility, consenting women were enrolled in the study, had 
a baseline interview and started with their allocated supplements to be taken daily for 
a period of two months. Women were home-visited once each week by the village 
nurse to replenish supplements and to monitor compliance by counting and recording 
the number of supplements that were taken.  
    The study was approved by the ethical review committees of the Medical College 
of Qingdao University. Written consent was given by each subject at the start of the 
trial. The subjects in the placebo group in our study have been given iron 
supplementation with NaFeEDTA or food rich in iron, such as the hemachrome-iron 
being from animal foodstuff, such as meat, fish and sea food, immediately after the 
trial. 
Sample collection and laboratory analyses 
Before and at the end of the intervention, overnight fasting (>12 h) blood samples 
(about 5mL) were collected from subjects by venipuncture into heparinized tubes 
between 6 and 8 o’clock in the morning; moreover, daily sample collection was 
evenly distributed over each of the groups. Hemoglobin concentrations were 
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measured in heparinized blood. Plasma was separated from the remainder of the 
blood by centrifugation at 2000 × g for 15 min at 4°C. The samples were transported 
on dry-ice and stored frozen at -80 °C until analysis for measurements of 
hematological indices and oxidative stress parameters. The baseline and final 
samples were analyzed in duplicate during the same analytic run.  
Hemoglobin concentration was measured by the cyanomethemoglobin method by 
using HemoCue for confirmation. A cutoff value of anemia was Hb<110g/L. 
Measurements of serum ferritin were performed by radioimmunoassay 14. Plasma 
iron concentrations were analyzed by atomic absorption spectrometry on an Analyst 
3100 Analyzer (Perkin Elmer Life Sciences, Wellesley, MA). The soluble transferrin 
receptor (sTfR) assay was performed using a commercial kit (R&D Systems, 
Minneapolis, MN). According to the instruction of the kit, the central 95th percentile of 
the reference distribution of sTfR concentration is 4.0 mg/L to 9.1 mg/L. The cutoff 
value of iron deficiency was >9.1mg/L. All sTfR assays were performed in duplicate. 
Total iron-binding capacity (TIBC) was determined by a turbidimetric method. A 
standard curve for each analyte was constructed from authentic standards. Standard 
concentrations were calculated on the basis of their known extinction coefficients. 
The activities of superoxide dismutase (SOD) and glutathione peroxidase (GSH-
Px) were determined in plasma as U/ml and IU/ml, respectively15. One unit of SOD 
activity was defined as the amount of protein causing 50% inhibition of the nitroblue 
tetrazolium salt reduction rate. The malondialdehyde (MDA) concentration was 
determined by using the thiobarbituric acid reaction. The MDA, an end product of 
fatty acid peroxidation, reacts with thiobarbituric acid to form a colored complex that 
has maximum absorbance at 532 nm. MDA concentrations were calculated by 
comparing the absorbance values of the samples with those of standard MDA 
solutions. Results were expressed as μmol/L blood16. All oxidative indicators were 
calculated from their standard curves. 
Statistical analysis  
Continuous data are presented as mean±SD or mean±SEM. Baseline variables 
were compared across three groups using a general linear model ANOVA. Mean 
changes over the intervention period and differences between groups and 95% 
confidence intervals (CI) were estimated for hematologic indicators and oxidative 
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indicators and tested with Student t-tests. The SPSS 18.0 package was used for all 
analyses. A p< 0.05 was considered as a significance level for all tests. 
RESULTS 
In the intervention study, complete data were available on 147, which is 96.1% 
of the original number of 153, pregnant women. 6 women did not complete the trial 
for the following reasons: 4 moved to other villages; 2 stopped taking supplements 
during the trial. Moreover, compliance was excellent, because study subjects were 
motivated by the offer of free medical care and all women were visited weekly by 
village nurses, who counted leftover capsules, provided new supplies, and gave 
support in case of any problems or questions related to the study. At the end of the 
trial, there were no substantial differences between the groups in any of the baseline 
characteristics (Figure 6.1 and Table 6.1). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
153 anemic pregnant women screened  
at 12 to 24 weeks of gestation 
placebo 
 (n=51) 
NaFeEDTA 
supplemented  
(n=51) 
ferrous sulfate  
supplemented 
(n=51) 
Moved out, n=1 Moved out, n=2; 
Drop off, n=1 
Moved out, n=1; 
Drop off, n=1 
Analyzed  
(n=48) 
Analyzed 
 (n=50) 
Analyzed 
 (n=49) 
2 months trial, home visit once week 
Figure 6.1 The trial profile. After ascertainment of eligibility, 153 consenting 
pregnant women were enrolled in the study. After 2 month trial, complete data 
were available on 147.There were no substantial differences between the groups 
in any of the baseline characteristics.  
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After the 2-months supplementation, significant changes in the placebo group were -
3.64 g/L in Hb concentration, 0.87 mg/L in sTfR, -1.23 μmol/L in plasma iron and -
1.59 μg /L in ferritin compared with baselines (all p values <0.05). Considerable 
increases in hematologic indicators were: 20.5 and 21.8 g/L for Hb (all p values 
<0.001); 4.8 and 7.2 μmol/L for plasma iron (both p values <0.001), 2.6 and 9.0 μg /L 
for ferritin (both p values <0.05); and decreases in TIBC: 31.4% and 26.6% (both 
values p<0.001) in I and IE groups, respectively, compared with the control group 
(Table 6.2). The differences of plasma iron and ferritin were 2.38 μmol/L and 6.37 μg 
/L, also significantly greater in the IE group than in the I group (both p values <0.001). 
The changes in oxidative stress parameters are presented in Table 6.3. 
Compared with C, increases of GSH-px activities were 32.6 IU/ml and 75.3 IU/ml in I 
and IE groups(both p values <0.05), respectively; the levels of MDA decreased by 
0.70 and 1.11 μmol/L in the twotreated groups (both p values <0.05), respectively. 
Moreover, the increase of GSH-Px activity was 42.7 IU/ml greater in IE group 
compared with I group (p<0.001).  
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Table 6.1 Characteristics of subjects at baseline 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
Indicators and abbreviations: Hb, hemoglobin concentration; PI, plasma iron; sTfR, soluble transferrin receptor; TIBC, total iron-binding  
capacity; MDA, malondialdehyde; SOD, superoxide dismutase; GSH-Px, glutathione peroxidase. 
2
group C as placebo, group I supplemented  
with 60 mg iron as ferrous sulfate; group IE with 60 mg iron as NaFeEDTA; 
3
p-value of the difference across treatment groups tested by one  
way ANOVA.  
Indicator
1
 
All baseline C
2
 I
2
 IE
2
 
p
3
 
mean SD mean SD mean SD mean SD 
n 153 51 51 51  
Age, years 28.1 3.6 27.6 3.3 28.4 3.5 28.4 3.6 0.394 
Gravidity 1.33 0.47 1.29 0.46 1.37 0.49 1.33 0.48 0.707 
Gestational stage, wk 21.4 4.69 21.2 4.75 21.5 4.48 21.5 4.92 0.936 
Hb, g/L 100.0 7.9 102.0 9.0 99.9 6.1 99.8 8.0 0.164 
sTfR, mg/L 10.5 2.2 10.2 2.8 11.0 1.78 10.5 2.20 0.132 
PI, μmol/L 12.2 2.93 12.7 3.13 11.9 2.00 11.9 3.43 0.275 
Ferritin, μg/L 12.7 4.78 13.1 5.28 13.1 2.58 11.8 5.83 0.313 
TIBC,  % 80.7 11.4 78.7 10.5 81.8 10.6 81.7 11.4 0.312 
MDA, μmol/L 5.21 1.53 5.11 1.25 5.54 1.88 4.97 1.34 0.137 
SOD, U/ml 76.9 28.7 73.5 34.1 75.9 23.4 81.2 27.5 0.378 
GSH-Px, IU/ml 117.0 26.5 111.0 26.3 119.0 26.7 121.0 25.8 0.131 
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Table 6.2 Changes and differences of indicators for hematological status in three groups 
 
1
Indicators and abbreviations:  Hb, Hemoglobin concentration; PI, plasma iron; sTfR, soluble transferrin receptor; TIBC, total iron-binding capacity.
 2
group C as placebo,  
group I supplemented with 60 mg iron as ferrous sulfate; group IE with 60 mg iron as NaFeEDTA; 
3
Changes: value at end of trial subtracted from baseline value within  
group; 
4
Differences: changes in the group I (or IE)- changes in the control group, espectively;
5
Differences:changes in the group IE- changes in the group I. 
 
 
Indicator
1
 Group
2
 n 
Changes
3 
 Difference
4
 Difference
5
 
mean 95%CI P value mean 95%CI p value mean 95%CI p value 
Hb, 
g/L 
C 50 -3.6 -6.6, -0.4 0.026 -- -- -- -- -- -- 
I 48 19.4 16.3, 22.8 <0.001 20.5 17.3, 23.8 <0.001 -- -- -- 
IE 49 20.8 17.6, 24.1 <0.001 21.8 18.9, 25.1 <0.001 1.30 -1.98, 4.58 0.435 
sTfR, 
mg/L 
C 50 0.87 0.14, 1.60 0.019 -- -- -- -- -- -- 
I 48 -4.37 -5.10, -3.36 <0.001 -5.20 -5.94, -4.46 <0.001 -- -- -- 
IE 49 -5.61 -6.35, -4.87 <0.001 -5.70 -6.44, -4.95 <0.001 0.49 -1.24, 0.26 0.196 
PI,  
μmol/L 
C 50 -1.23 -2.12, -0.34 0.007 -- -- -- -- -- -- 
I 48 4.40 3.50, 5.30 <0.001 4.81 3.91, 5.72 <0.001 -- -- -- 
IE 49 6.75 5.86,7.65 <0.001 7.19 6.29, 8.09 <0.001 2.38 1.47, 3.29 <0.001 
Ferritin,μg
/L 
C 50 -1.59 -3.15, -0.02 0.047 -- -- -- -- -- -- 
I 48 0.98 -0.61, 2.56 0.226 2.63 1.04, 4.22 0.001 -- -- -- 
IE 49 8.62 7.05, 10.2 <0.001 8.99 7.41, 10.6 <0.001 6.36 4.76, 7.96 <0.001 
TIBC,  
% 
C 50 3.11 -0.31, 6.52 0.075 -- -- -- -- -- -- 
I 48 -31.3 -34.8, -27.9 <0.001 -31.4 -34.8, -27.9 <0.001 -- -- -- 
IE 49 -26.4 -29.8, -23.0 <0.001 -26.6 -30.0, -23.1 <0.001 4.80 1.13, 8.29 0.007 
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Table 6.3 Changes and differences of oxidative stress in MDA, GSH-Px and SOD in three groups 
Indicator
1
 Group
2
 n 
Changes
3
 Difference
4
 Difference
5
 
mean 95%CI P value mean 95%CI p value mean 95%CI p value 
MDA, 
μmol/L 
C 50 0.17 -0.33, 0.66 0.502 -- -- -- -- -- -- 
I 48 -1.11 -1.61, -0.61  <0.001 -0.70 -1.20, -0.20  0.006 -- -- -- 
IE 49 -0.91 -1.40, -0.41 <0.001 -1.12 -1.61, -0.62 <0.001 -0.41 -0.92, 0.09 0.108 
SOD,  
U/ml 
C 50 1.19 -9.87, 12.3 0.832 -- -- -- -- -- -- 
I 48 0.22 -11.0, 11.4 0.696 1.47 -9.76, 12.7 0.797 -- -- -- 
IE 49 -11.7 -22.8, -0.6 0.039 -5.10 -16.3, 6.07 0.370 -6.57 -17.9, 4.7 0.253 
GSH-Px, 
IU/ml 
C 50 10.6 -4.23, 25.5 0.160 -- -- -- -- -- -- 
I 48 29.5 14.2, 44.3 <0.001 32.6 17.5, 47.7 <0.001 -- -- -- 
IE 49 66.2 51.3, 81.1 <0.001 75.3 60.3, 90.3 <0.001 42.7 27.5, 57.9 <0.001 
 
1
Indicators and abbreviations: MDA, malondialdehyde; SOD, superoxide dismutase; GSH-Px, glutathione peroxidase. 
2
group C as placebo, group I supplemented  
with 60 mg iron as ferrous sulfate; group IE with 60 mg iron as NaFeEDTA; 
3
Changes: value at end of trial subtracted from baseline value within group;  
4
Differences: changes in the group I (or IE)- changes in the control group, respectively; 
5
Differences:changes in the group IE- changes in the group I. 
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DISCUSSION 
After 2 months trial, both NaFeEDTA and ferrous sulfate supplementation in 
anemic pregnant women did not only significantly improve hematologic indicators, 
but also reduced oxidative stress, as shown by increased GSH-Px activities and 
decreased levels of MDA. An additional effect was found in iron status and GSH-Px 
activity for NaFeEDTA compared to ferrous sulfate supplementation.  
Normal human pregnancy is considered to be a state of enhanced oxidative 
stress, which may play an important role in embryo development, implantation, 
placental development and function, foetal development, and labour in pregnancy 17. 
However, pathologic pregnancies including gestational diabetes mellitus (GDM), 
obesity and hypertensive disorders are associated with a heightened level of 
oxidative stress 18-20. Maternal undernutrition, particularly at a time that includes 
pregnancy, results in reduced offspring ovarian follicle numbers and may be 
mediated by increased ovarian oxidative stress coupled with a decreased ability to 
repair the resultant oxidative damage 21. Untreated iron deficiency is deleterious, 
while iron overload could promote the generation of free radicals and result in cellular 
damage22. It is, therefore, important to maintain optimal iron intake 23. Low doses of 
oral ferrous iron (36mg/d) did not unfavorably change the physiological pattern of 
parameters of oxidation24. Daily supplementation of 100mg iron as ferrous sulfate 
during the second half of pregnancy was recommended to address the 
corresponding iron requirements25, and risks associated with oxidative stress were 
not observed in women supplemented with 120mg iron once or twice per week26. 
Suggested guidelines are 80-100mg ferrous iron daily, for which there are no 
documented side effects5. In our study, the moderate supplementation with 60mg/d 
iron has been beneficial to improving hematological status and oxidative stress 
parameters. We found that MDA levels, a marker of lipid peroxidation, were 
significantly decreased and GSH-Px activity increased in two supplemented groups, 
which indicates that the moderate iron supplementation improved oxidative status 
without increased deleterious effects.  
    Unfortunately, the hematologic status of pregnant women in the second or third 
trimester of pregnancy in the placebo group deteriorated after the trial, and the 
changes of Hb concentration, ferritin and plasma iron levels decreased, which might 
be contributing to blood volume expansion and iron deficiency. During the period of 
pregnancy, plasma volume expands by 25% to 80% of pre-pregnancy volumes27. 
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Pregnant women have an increased demand for iron to expand about 30% of their 
erythrocyte mass and generate the iron supply to the growing fetus28, which results in 
a decrease of hematocrit of about 3% to 5% between gestational weeks 20 and 3029. 
Therefore, 80-100 mg ferrous iron/day for women with iron deficiency (ID) and iron 
deficiency anemia (IDA) should be recommended30. 
With respect to changes of iron supplementation and oxidative stress 
parameters in this study, subjects also had significantly higher glutathione peroxidase 
activity and low level of plasma MDA after iron supplementation. This finding is in 
accordance with previously reported data in human and animal models31,32. Ferrous 
iron is the form that is mostly used for correction of iron deficiency, and a central pro-
oxidant that propagates free radical reactions through Fenton chemistry both locally 
(in the gastrointestinal tract) and systemically. An excess of pro-oxidants over 
antioxidants results in oxidative stress, but there was no increase in the markers of 
oxidation or inflammation studied. Moreover, we could not find any indication of an 
increase of oxidative stress after iron supplementation. On the contrary, the 
moderate dose of iron may be beneficial both in improving anemia and decreasing 
the status of oxidative stress during pregnancy. 
    NaFeEDTA might be a better form of iron supplements than electrolytic iron 33. Iron 
absorption from NaFeEDTA might be two to three times higher than from electrolytic 
iron 34. NaFeEDTA increased both Hb concentration and serum ferritin concentration 
substantially in iron deficient populations 35. At least 10 mg/d iron as NaFeEDTA 
would be necessary to prevent iron deficiency anemia, even in those populations 
relying for their subsistence on vegetable food only, although those suffering from 
severe anemia would require more than 10 mg/d 36. 
Several studies showed that NaFeEDTA is more suitable than electrolytic iron in 
children 10,37, but few reports were related to anemic pregnant women. The study 
showed that iron deficiency among pregnant women untreated in the middle trimester 
of pregnancy might deteriorate in the third trimester in both hematologic status and 
oxidative stress; and moderate iron supplementation has been beneficial to 
improving iron deficiency and oxidative stress, and NaFeEDTA is better than ferrous 
sulfate. Thus, based on the results from this study, we suggest that iron 
supplementation with NaFeEDTA should be recommended for anemic pregnant 
women. Surprisingly, almost none of the subjects with poor nutritional status took 
dietary supplements, including iron. Our study has important public health 
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implications. It underlines the need for a comprehensive nutritional policy for this 
target population. Besides improving their diet, NaFeEDTA supplementation may be 
worthwhile for pregnant women in rural China.  
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According to a World Health Organization (WHO) review of nationally representative 
surveys from 1993 to 2005, 42% of pregnant women have anemia worldwide. Almost 
90% of them reside in Africa or Asia (1). Chinese pregnant women are probably 
seriously at risk of anemia (2) and micronutrient deficiency (3), especially in the rural 
areas; but information is still insufficient, and the optimal treatment should be 
determined (4). Although being an essential trace element, iron plays a central role in 
generating harmful oxygen species. In rats, both iron deficiency and excess result in 
free radical mitochondrial damage (5), however, whether iron deficiency or iron 
supplementation in anemic pregnant women result in an increase of oxidative stress 
is unclear.  
The general aim of this thesis was to investigate the prevalence of anemia, and 
micronutrient status in Chinese pregnant women, and to examine effects of 
supplementation with iron and other micronutrients on anemia and micronutrient 
status, and on oxidative stress. In this final chapter, we will firstly provide a brief 
overview of the main findings of the research; secondly, methodological issues, 
including epidemiological considerations, internal validity and external validity, will be 
discussed. Finally, conclusions, research recommendations and the implications for 
public health will be given.  
 
MAIN FINDINGS 
Anemia and micronutrient status 
In order to have a representative picture of anemia in Chinese pregnant women in 
rural areas, we carried out a cross-sectional study among 6413 pregnant women 
aged 24～37 in the third trimester of pregnancy in five rural areas in four provinces, 
situated in the east, the southeast, the northwest and the southwest of China. The 
overall prevalence of anemia was 58.6%, ranging 48.1%~70.5% in the five areas. In 
a random subset of 734 women micronutrient status was determined. We found that 
serum ferritin levels were lower in anemic than in nonanemic women. Subnormal 
serum iron, iron depletion and subnormal vitamin A and ascorbic acid were 
significantly more frequent in anemic subjects. Subnormal concentrations of vitamin 
B2 in urine and B12 in serum were frequent in both anemic and non-anemic groups. 
These results indicate that anemia is still a severe health problem in the Chinese 
rural area, and deficiency or subnormal status of iron and other micronutrients are 
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even more frequent. 
Supplementation studies   
Anemia  
Because of the findings in the cross sectional study, we investigated the effect of 
supplementation with riboflavin (1mg) and retinol (2000μg) and their combination on 
a background of iron and folic acid in a 2 months randomized double blind trial. 
Hemoglobin (Hb) concentration increased in all 4 groups (p<0.001). The increases in 
the combination, retinol and riboflavin groups were respectively 5.4 g/L, 3.62 g/L and 
1.78 g/L greater than in the reference group (iron and folic acid), and also the 
reductions in the prevalence of anemia (Hb<110g/L) and iron deficiency anemia were 
significantly greater in the three groups. The literature reports that ferrous sulphate 
supplements may cause gastrointestinal side effects, such as upper abdominal 
discomfort, nausea, and constipation (6,7). Our study showed that subjective well 
being was better, and gastrointestinal symptoms were less in the riboflavin and 
combination groups than in retinol and the reference group. These findings imply that 
retinol and riboflavin have additional effects on anemia, and that riboflavin can 
prevent or improve gastrointestinal side effects of the iron supplement. 
Oxidative stress 
Pregnancy, subnormal hematological status and iron supplementation may all 
increase oxidative stress. Free radicals that are produced in this situation can attack 
the erythrocyte membrane and decrease its fluidity. The trial we designed 
investigated such changes in anemic pregnant women. We found that GSH-px 
activities increased, and levels of MDA decreased in both iron (I), and iron combined 
with vitamin groups (IM), but more in IM. Erythrocyte membrane fluidity was 
evaluated using fluorescence polarization (ρ) and microviscosity (η), lower values of 
which indicate better membrane fluidity (8, 9). After the trial, the ρ and η values 
compared with placebo, decreased in I, IF and IM groups. The decreases were 
greatest in the IM group. This trial showed that a combination of retinol and riboflavin, 
and iron not only improves hematological status, but also oxidative stress. 
NaFeEDTA supplement  
Both ferrous sulphate and sodium iron ethylenediaminetetraacetate (NaFeEDTA) are 
used as iron supplements (10) and NaFeEDTA is thought to have superior 
bioavailability. We designed a trial to compare effects of NaFeEDTA and ferrous 
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sulfate on improving hematological status and oxidative stress. During the trial, 
considerable increases of hematologic indicators, such as Hb, plasma iron, ferritin, 
were observed both in ferrous sulfate and NaFeEDTA groups, compared with the 
control group. Glutathione peroxidase (GSH-Px) activities were increased, and 
malondialdehyde (MDA) levels decreased in ferrous sulfate and NaFeEDTA groups, 
compared with placebo. Moreover, the effects were much better in NaFeEDTA than 
ferrous sulphate groups. The results indicate that deteriorating anemia in the second 
trimester can be improved by iron supplementation, whereas NaFeEDTA has 
superior effectiveness compared with ferrous sulfate. 
 
METHODOLOGICAL ISSUES 
In this section, we will discuss a few important methodological issues, in addition to 
what was already discussed in previous chapters. Aspects regarding study 
population and design in relation to internal and external validity will be addressed. 
 
Internal validity 
Cross-sectional study design 
The five field sites we selected in the cross sectional study, were geographically 
located in the east, northwest, southeast, southwest and middle of China. Their 
economic level ranges from middle to poor and poverty-stricken. We believe that our 
results, prevalence of anemia and micronutrient status, are representative for healthy 
pregnant women in these five areas. 
All subjects were randomly enrolled from the local population of pregnant women 
reporting for regular pregnancy examination. Information was collected on maternal 
socio-demographic characteristics and clinical history at enrollment. Duration of 
pregnancy was calculated on the basis of the woman’s reported date of last menses 
as well as by clinical indication.  
Intervention study design 
In order to investigate effects of iron supplement (FeSO4 or NaFeEDTA), and 
combined multiple micronutrients on hematological status, anemia and oxidative 
stress, we designed three supplementation trials, all carried out in Shen County, an 
area in the centre of China with 960,000 inhabitants (see Figure 1.1 in chapter 1).  
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The first study (trial 1 in Figure 4.1) was a 2-mo double-blind randomized 
supplementation trial of retinol and riboflavin on a background of iron and folic acid in 
a two-by-two factorial design, conducted in 2002-2005 and reported in chapter 4. A 
cutoff value of Hb ≤105g/L was taken for anemia in the study, since this was 
expected to give a larger effect size. A total number of 366 anemic pregnant women 
with 80g/L<Hb≤105g/L, were selected. Of them 342 finished the trial and supplied 
blood for the Hb and ferritin analyses. 
The recruitment for the first subject began in April, 2003. After recruitment of 172 
subjects from 128 villages distributed in 8 communities, unfortunately, the trial had to 
be stopped because of the SARS epidemic. We were not able to follow them up 
according to protocol and had to give up the 172 subjects, and start all over again, 
including finding additional financial support. Finally, the Nestlé Foundation agreed to 
supplement an additional grant.  
In chapter 5, a second intervention study (trial 2 in Figure 5.1) was described to 
examine the effects of the supplements on hematological status and oxidative stress 
in anemic pregnant women; which was carried out from 2004-2006. A total of 164 
pregnant women, at 12 to 24 weeks gestation, anemic with hemoglobin <110g/L, 
were allocated to the intervention groups by order of enrollment. In the intervention 
study, complete data were available on 145, which is 88.4% of the original number of 
164 pregnant women.  
The third trial (trial 3 in Figure 6.1) aimed to assess whether moderate dose 
NaFeEDTA and ferrous sulfate supplementation can improve both hematologic status 
and oxidative stress in anemic pregnant women, and to confirm whether NaFeEDTA 
was superior (Chapter 6). It was conducted from 2002 to 2005. 153 anemic pregnant 
women, with 80≤Hb<110g/L, were randomly allocated. Finally, complete data were 
available on 147 women, which is 96.1% of the original number of 153. 
Selection of subjects 
All three trials were conducted in Shen county, China, which has a population of 
pregnant women of about 10.000 yearly, 60% of whom have anemia in the third 
trimester of pregnancy. In all three trials we used a similar study design, i.e. a 2 
months randomized double-blind controlled study. The sample sizes were calculated 
given a two-sided significance level of 0.05 and a power of 0.80, by the formula, 
n=2(((t2+t2)*SE)
2/), (t2=1.645, t2=1.282). Sample sizes per group are calculated 
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for minimal relevant differences between treatment and reference. An increase of 3 
g/L () in IFA and IFB compared with the IF and an additional increase of 3 g/L 
compared with the IFA and the IFB group in chapter 4; and the sample size was 
calculated based on a difference in hemoglobin (Hb) change (δ) of about 5 g/L 
between the intervention groups and placebos in chapter 5 and chapter 6. Moreover, 
an addition of 5% to 10% subjects was considered for dropping out per group. In the 
trials in Chapter 4, 5 and 6, subjects were allocated to the intervention groups by 
registration number, for example, in chapter 4, subjects 1, 5, 10, 15, 20, etc. were 
allocated to the group receiving iron and folic acid. We assumed that the order of 
recruitment was random.  
Compliance and dropping out  
During the trials in chapter 4, 5 and 6, we found that 24, 19 and 6 subjects, 
respectively, did not complete the study for the following reasons: moved to other 
villages, preterm delivery. A few stopped taking supplements or dropped out without 
reasons. This drop out and the underlying reasons were evenly distributed over the 
groups. Due to restriction to the amount of blood (some subjects were not willing to 
give more than 3 ml of blood), we had missing data on a number of hematologic 
variables or antioxidative parameters. These were reasonably evenly distributed over 
the groups and the remaining groups were still balanced with respect to important 
characteristics. At the end of the trials, there were no substantial differences between 
the groups in any of the baseline characteristics. 
The small percentages of drop out indicate excellent compliance of the subjects, 
probably because they were motivated by the offer of free medical care and all 
women were visited weekly by village nurses. During the trial, a village nurse was 
responsible for recruitment of the subjects and the distribution of the supplements. 
After ascertainment of eligibility, consenting women were enrolled in the study to 
receive their allocated daily supplements for a period of two months. Women were 
home-visited once each week by the village nurse to replenish supplements and to 
monitor compliance by counting and recording the number of supplements that were 
taken. The village nurses also provided counseling about possible side effects of 
taking the supplement. So we believe that compliance in our studies was excellent 
and that they were well supervised. 
Treatments  
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In the trials of chapter 4, 5 and 6, the supplements were prepared in colored 
capsules and manufactured by Hurun’ company (a Chinese food-additive company, 
Beijing). Trial participants and the research team were unaware of the treatment 
assignment. The trial was deblinded after the analysis of the primary outcomes. 
Moreover, the quality of the supplements was assured by storage at -200C and 
micronutrient levels were examined every three months, showing no appreciable 
changes. Although the treatment capsules unfortunately had different colors for 
different groups, blinding of both participants and study personnel stayed intact, since 
there was no need to break the code before the main analyses had been carried out. 
In our trial, most subjects only knew their own supplement which was provided by 
their village nurse. Since they lived in a remote area, contacts with other trial 
participants were rare, and we did not find any change of supplements between 
subjects in the groups.  
Sample collection and analyses 
Overnight fasting (>12h) blood samples in the cross sectional study, and before and 
at the end of the intervention trials were collected between 6 and 8 am. Moreover, 
daily sample collection was evenly distributed over each of the groups. Urine 
samples (10mL) were collected for riboflavin and creatinine analyses, and 
immediately aliquoted. The samples were transported on dry-ice and stored frozen at 
-80 °C until analysis. The baseline and final samples were analyzed in duplicate 
during the same analytic run in all studies reported in chapters 2, 3, 4, 5 and 6. 
Erythrocyte membrane fluidity was evaluated using fluorescence polarization (ρ) and 
microviscosity (η); lower values indicate better membrane fluidity in chapter 5. 
Although fluorescence polarization was used to assess membrane fluidity in past 
decades, now it is frequently applied in oxidative stress (11), erythrocyte aggregation 
(12), understanding of membrane protein function (13), etc. Especially the 
noninvasiveness of the method makes it suitable for clinical applications (14). Up to 
now, few studies evaluated changes of both hematologic status and erythrocyte 
membrane fluidity after iron supplementation in anemic pregnant women, possibly 
because erythrocyte membrane preparation is quite laborious. However, it could be 
an effective biomarker for evaluating hematological status and oxidative stress 
simultaneously. 
 
External validity 
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China has a high prevalence of anemia in pregnant women in undeveloped areas. In 
some counties, the prevalence of anemia may be a serious public health problem. 
The overall prevalence of anemia among pregnant women was 39.6 % from 1993 to 
2005, and anemiaprevalence increased from the first (29.6%) to the second (33.0%) 
and third (56.2%) trimesters in South-EastChina, (15). These results are quite similar 
to our findings. Therefore, the findings of this thesis are expected to be valid for the 
population in other rural areas.  
This cross-sectional study was conducted in geographically different areas 
nationwide, i.e. the east (Laixi, Qingdao), the southeast (Fuqing, Fujian), the 
northwest (Lanzhou), the southwest (Guiling), and the middle (Shen county) of China. 
These five counties are less developed rural areas. The population sizes are 0.96, 
0.73, 1.23, 0.98 and 1.87 millions in Shen county, Laixi county, Qingdao; Fuqing 
county, Fujian; Guilin; Lanzhou; respectively. Compared with the few similar studies 
carried out so far (16,17), ours had a relatively wide distribution and large source 
population with a total of 5.77 millions. Similar to other rural areas in China, farming 
remains the main occupation of the local population, mainly living on a plant food diet.  
In line with these findings, we observed that low education or training was strongly 
associated with a high prevalence of anemia. The prevalence was 66.5% in primary 
school women in rural areas. Compared to women villagers, pregnant women in 
cities get more health improvement information from hospitals or medical centers, 
books, television, and even internet (18). In line with this, it was reported by others 
that the prevalence of anemia in the third trimester (56.2 %) was higher in women in 
rural areas who were farmers and had less education than women in towns or cities 
of south-east China (19). Iron deficiency is a major cause of anemia and the most 
prevalent nutrient deficiency among pregnant women in developing areas (20). 
Similarly, we found that poor heme iron diet or plant food diet in rural areas was one 
of most important factors causing anemia, iron deficiency, and micronutrient 
deficiencies as well in our previous study (21). The results of our supplementation 
trials are comparable to most previous supplementation trials conducted in other 
regions in China, showing that supplementation with iron, micronutrients and a 
combination significantly decreased the prevalence of anemia and improved 
hematological status (22) and oxidative stress (23,24).In rural areas, people typically 
consume a low iron diet with a lot of grain and small amounts of animal food. They 
also seldomly eat fresh fruits (25). Therefore iron and micronutrients supplements are 
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necessary to prevent iron deficiency and anemia. Thus, the supplementation with a 
combination of iron (ferrous sulfate or NaFeEDTA) and multiple vitamins is not only 
effective, but also more feasible for anemic pregnant women in poor rural areas or 
remote areas nationwide. 
In conclusion, based on internal and external comparisons, we conclude that our 
study population was representative for Chinese rural areas, and our findings are 
close to those findings in other rural regions with high prevalence of anemia in China. 
Moreover, supplementation trials with iron (ferrous sulfate or NaFeEDTA) and/or 
multiple vitamins, were beneficial to decreasing anemia and improving oxidative 
stress in anemic pregnant women in one of five research sites. Considering the study 
population, our findings from the supplementation trials should not be extrapolated to 
urban areas and other populations without iron and micronutrient deficiencies. 
 
INTERPRETATION OF FINDINGS 
Nutritional anemia and iron deficiency 
The overall prevalence of anemia in pregnant women, was 58.6% in chapter 2, and 
anemia during pregnancy was defined according to WHO guideline (Hb<110g/L). We 
know that serum ferritin should be measured as a better indicator for diagnosing iron 
deficiency or iron deficiency anemia, but we were not able to accomplish that 
because the measurement of ferritin by radioimmunoassay was too expensive to be 
carried out in so many samples (6413). So our study aimed to investigate the 
prevalence of overall anemia, which includes iron-deficiency anemia (IDA), 
cobalamin-deficiency anemia, folate deficiency anemia, copper deficiency anemia, 
etc. The prevalence of nutritional anemia is considered to be related to deficiencies 
of multi-nutrients, and more than 85% of the nutritional anemia is iron deficiency 
related, or of iron combined with folate or other nutrient deficiencies.  
Anemia and micronutrients 
In chapter 3, the results showed that micronutrient status was significantly lower in 
anemic women than non anemic women for serum vitamin C, serum retinol and 
vitamin B2 in urine. Serum subnormal vitamin A was significantly more frequent in 
anemic than in non anemic subjects. Although the most common cause of anemia is 
iron deficiency, deficiencies of vitamin B12, folate, vitamin A and even zinc contribute 
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either singly or in combination to maternal anemia (26). Women in developing 
countries have a high prevalence of iron deficiency but also tend to be deficient in 
other micronutrients such as vitamin A, folate, etc. (27). This implies that iron 
deficiency rarely occurs in isolation and is often accompanied by other micronutrient 
deficiencies (28). Makola (29) confirmed that micronutrient deficiencies are prevalent 
in the female population of Tanzania as well as the prevalence of anemia (63%). In 
our study, for retinol and ascorbic acid there were frequent marginal deficiencies in 
pregnant women with anemia. The extra requirement of the fetus and the mother and 
low intake will both have contributed. These women often show poor nutritional 
status, lacking sufficient dietary intake of multiple micronutrients, such as from green 
vegetables and animal foods. The present study indicates that anemia in pregnant 
women is still a severe nutrition related problem nowadays. It is hypothesized that 
the reasons for the difference in prevalence between the five sites were geographic 
differences, in unbalanced diets and poor nutritional education (30). 
Role of retinol and riboflavin in anemia 
An additive effect of retinol and riboflavin on hematologic parameters and anemia on 
top of iron and folic acid was found in chapter 4. This may be explained by the co-
existing deficiencies of these micronutrients in our population. The effects of retinol 
and riboflavin appeared to be additive and we did not find evidence for interaction. 
This may indicate that the beneficial effects of each of the vitamins on erythropoiesis 
are independent. It is well known that retinol plays an important role in reducing 
anemia and improving iron status. Retinol enhances iron utilization by stimulating 
erythropoiesis and iron metabolism by raising mean red cell volume, plasma Fe 
concentration and total Fe-binding capacity (31,32).  
Improvement of poor appetite was observed in 42.2% and 41.0% of the IFB group 
and IFAB group, respectively in chapter 4. Riboflavin is thought to improve iron 
uptake and absorption by improving the gastrointestinal function (33) and better 
appetite, which may have resulted in significantly enhanced concentration of serum 
iron (34). Consistently, women who took riboflavin had better appetites (subjectively) 
than those who did not take any riboflavin. At the same time, riboflavin is also 
necessary for synthesis of the globin component of hemoglobin (35). 
After 2 months of supplementation in chapter 5, anemic pregnant women had more 
antioxidative capacity, i.e. lower levels of circulating lipid peroxidation products (MDA), 
and higher GSH-Px activity and higher vitamin concentrations, such as retinol, 
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riboflavin, etc. Several studies have shown that micronutrient supplementation 
improves the glutathione peroxidase (GSH-Px) activities and decreases levels of 
malondialdehyde (MDA) (36,37), and antioxidant supplementation, such as vitamins 
A, B12, C, E, folic acid, etc., was associated with better maternal and perinatal 
outcome in pregnant women with low antioxidant status than supplementation with 
iron and folate alone (38).  
Iron supplementation and oxidative stress 
Transitional metals, especially iron, which are particularly abundant in the placenta, 
are important in the production of free radicals (39). Increased iron levels may be 
responsible for placental oxidative stress and abnormalities in antioxidants (40). Iron 
overload could promote the generation of free radicals and result in cellular damage 
(41), but low doses of oral ferrous iron (36mg/d) did not unfavorably change the 
physiological pattern of parameters of oxidation (42). The question that should be 
addressed is whether presently recommended iron supplementation schemes and 
doses reduce or increase oxidative stress by correcting iron deficiency. The evidence 
for this is almost nonexistent. Daily supplementation of 100mg iron as ferrous sulfate 
was recommended during the second half of pregnancy to address the 
corresponding iron requirements (43), and risks associated with oxidative stress were 
not observed in women supplemented with 120mg iron once or twice per week. In 
our study in chapter 5 and 6, the daily dose of iron (ferrous sulphate and/or 
NaFeEDTA) was 60 mg. We found that the MDA levels, a marker of lipid 
peroxidation, were significantly decreased and GSH-Px levels increased in all 
supplemented groups. Erythrocyte membrane fluidity improved as well, which 
indicates that the iron supplementation did not deteriorate, but even improved 
oxidative status.  
 
CONCLUSIONS 
The prevalence of anemia in pregnant women is still high in China especially in rural 
areas, and no important changes in anemia among this vulnerable group have been 
observed in the last decade. These women often show poor nutritional status, lacking 
sufficient dietary intake of multiple micronutrients. Surprisingly, almost none of the 
subjects took dietary supplements, including iron. Our study showing additional 
benefits of vitamins in tackling the anemia problem has important public health 
implications. It underlines the need for a comprehensive nutritional policy for this 
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target population. Besides improving their dietary intake, multiple and moderate 
micronutrient supplements in pregnant women in rural China should be encouraged. 
Iron deficiency is prone to be accompanied by multiple micronutrients deficiency. Our 
study showed that hematological indicators of Hb concentration, plasma iron and 
ferritin, significantly decreased, and GSH-px activity decreased and MDA level 
increased in anemic pregnant women in the third trimester in the placebo group, 
compared with baseline two months before. These findings imply that iron deficiency 
among pregnant women untreated in the middle trimester of pregnancy might 
deteriorate in the third trimester in both hematologic status and oxidative stress. Iron 
supplementation did not increase oxidative stress in the form and supplemental 
levels as reported in this thesis. A moderate dose of iron, preferably combined with 
multivitamin supplementation is beneficial both in improving hematological status and 
in decreasing the status of oxidative stress during pregnancy. NaFeEDTA, as a 
choice of iron supplement for anemic pregnant women, showed better effect and less 
side effects than ferrous sulfate (44).  
 
FURTHER RESEARCH 
In this study in chapter 2, the distribution of hemoglobin concentrations showed that 
both lower (Hb <80g/L) and higher hemoglobin concentrations (Hb>140g/L) might 
result in deviating from the normal birth weight (2500g~4000g). Women with a high 
Hb concentration (Hb>130 g/L) had 20% higher risk of preterm delivery and 50 % 
higher risk of low birth weight (45). But this deserves to be confirmed in further 
studies. 
We reported the extent to which multiple deficiencies coexist in chapter 3, data that 
are scarce in rural developing country settings. The results in our study also have the 
potential to provide valuable reference values for assessing nutritional status. 
However, the assessment of vitamin and mineral status during pregnancy is 
complicated because there is a general lack of pregnancy-specific laboratory indices 
for nutritional evaluation (46). To improve this situation, networks for monitoring 
nutritional status of pregnant women should be established in larger rural areas 
nationwide.  
In our study in chapter 4, the combination of iron and folic acid had already a strong 
beneficial effect. The effects of retinol and riboflavin appeared to be additive and we 
did not find evidence for interaction. Further studies may focus ona possible 
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additional efficacy of higher dosages of retinol and/or riboflavin.  
We did not find any change of SOD activity during the trial. Some studies showed 
similar results (47) and even a decrease of SOD activity after antioxidant 
supplementation (48, 49). This aspect deserves further study. In our study, 
antioxidant defenses and oxidative stress appear to be favorably modulated even by 
iron supplementation alone. Such findings have not been reported in anemic 
pregnant women before, and further mechanistic studies are to be expected.  
 
IMPLICATIONS AND RECOMMENDATIONS 
Comprehensive anemia control for pregnant women should include different 
strategies applied in an integrated and coordinated way. Monitoring, health 
education, diet improvement, and supplementation are all part of such an approach.  
Network for monitoring anemia 
This thesis found that anemic pregnant women often have lower levels of retinol, 
zinc, riboflavin, etc., than nonanemic women. Thus, once a pregnant woman is found 
with ID or IDA, the status of other micronutrients should be examined. Therefore, 
anemia in pregnant women, as a severe public health problem in rural areas, 
deserves urgent attention, for instance in the form of a network for monitoring anemia 
in pregnant women nationwide, so that cases can be treated earlier.This network can 
initiate large scale prevalence investigations and interventions in order to improve the 
situation. 
Health education and training 
The level of education may influence the health and nutritional status of individuals. 
In this thesis, we found that the prevalence of anemia was significantly different 
according to educational level: 52.9%, 62.4% and 66.5%, respectively for college, 
secondary and primary education in Table 2 in Chapter 2. Subjects with better 
education can easily get health information from reading, communicating, and 
internet; however, most villagers only have primary education level, and have less 
access to health information. Thus, a comprehensive community-based intervention 
including iron supplementation, health education and communication through 
effective strategies may improve the haematological status of pregnant women in 
each trimester (50), in rural areas China. 
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Balanced diet and supplementation 
Staple grains vary from rice to wheat to corn and the main source of iron in rural 
areas in China is vegetables. Such diets include abundant amounts of cereals, 
legumes and vegetable components, such as phytate, fibres and soybean protein, 
which are inhibitory to non-heme iron absorption (51-53). Subjects selected in the 
cross sectional study were from five sites, which were developing or poor areas of 
the countryside. Therefore, one of the nutritional problems related to nutrient 
adequacy in their diets is iron deficiency, especially if soybean products are used as 
protein sources instead of animal products. Nevertheless, no subjects in this study 
took any supplement containing iron. This may imply that the general population in 
the areas studied was not aware of the risk of iron deficiency. Unlike Western 
societies, food in China is not routinely fortified with iron. Therefore, a balanced diet 
with food rich in iron, such as, meat or other animal food, should be supplied for 
pregnant women in rural areas. If this is not feasible, iron and micronutrient 
supplementation should be considered. 
Our experimental study showed that iron combined with folic acid supplementation 
decreased all anemia to 29.6% and iron deficiency anemia (IDA) to 15.9%; while iron 
combined with folic acid, retinol and riboflavin further decreased to 15.7% all anemia 
and 6% IDA in Table 4.4; which should be referred to the additional effects of retinol 
and riboflavin. Moreover, retinol and riboflavin treatments increased Hb 
concentrations with 3.62g/L and 1.78g/L, respectively; and the change of ferritin was 
greater in women treated with retinol than in those that were not. A successful 
intervention program needs a wonderful compliance. Oral supplementation with 
ferrous sulfate is an effective therapy, but gastrointestinal side effects may impair 
treatment compliance. A few studies tried to limit side effects by substituting a ferrous 
sulfate prolonged release formulation (PRF) for ferrous sulfate, and by using iron 
supplementation by intravenous route for replacing the oral (54-56). PRF effects still 
need to be confirmed and the price is relatively high. Parenteral administration is not 
feasible for the large population in poor rural areas. However, this study supplied the 
evidence that riboflavin could decrease gastrointestinal side effects caused by iron 
supplementation alone, and NaFeEDTA may has a similar effect. Therefore, adding 
riboflavin to iron supplementation may be a promising scheme for treating anemia, 
while NaFeEDTA may be a promising substitute for sulfate supplement. Based on 
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this evidence, our studies suggest that anemic pregnant women nationwide should 
take moderate dose iron and multiple micronutrients, sunch as folic acid, retinol, 
riboflavin, etc. supplementation in combination, which will be beneficial by reducing 
anemia and oxidative stress, and by increasing their well-being as well.  
In conclusion, eradicating anemia from rural areas will require a more comprehensive 
effort including establishing a network for monitoring anemia, health education, 
enhancing economic development, and supplementation programmes. 
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Summary 
Anemia is the scourge of the third world. Pregnant women are at risk especially 
during the last trimester of pregnancy. The prevalence of anemia (Hb<110g/L) in 
Chinese pregnant women in the third trimester was 48% in parts of urban areas 
during 1995-2000. Notwithstanding the fact that the diagnosis of anemia is fairly 
simple and the treatment is cheap, the overall prevalence of anemia was 39.6% 
among pregnant women from 1993 to 2005, and 29.6% in the first, 33.0% in the 
second and 56.2% in the third trimester in Jiangsu and Zhejiang provinces with top-
economic level in China, averaged over a period of 12 years. In rural areas, anemia 
may remain an even more severe public health problem among pregnant women in 
the third trimester because of lack of iron intake during the second and the third 
trimester of gestation, but also due to micronutrient deficiencies. Therefore, a cross-
sectional study was carried out to investigate the situation among pregnant women in 
rural areas of China. Furthermore we conducted three iron and micronutrient 
supplementation trials, in order to assess the effect on anemia, micronutrient status 
and to evaluate possible adverse effects.  
 
The prevalence of iron deficiency anemia (IDA), and deficiencies of micronutrients in 
pregnant women in rural areas nationwide is not well known. From 1999 to 2003, we 
conducted a large population based study in five rural areas, i.e. Qingdao in the east, 
Fuzhou in the southeast, Lanzhou in the northwest, Guilin in the southwest, and a 
suburban district of Liaocheng in the middle of China, which are less developed rural 
areas with different geographical conditions. In total, 6413 pregnant women were 
recruited and the overall prevalence of anemia was 58.6%, ranging 48.1%~70.5% in 
the five areas (Chapter 2).  
In addition, we simultaneously evaluated micronutrient status of a random subset of 
the subjects, in order to confirm whether deficiencies of multiple micronutrients co-
exist in anemic pregnant women. The findings showed that micronutrient status was 
lower in anemic women than non anemic women. Subnormal serum iron (<700µg/L) 
and iron depletion (ferritin<12µg/L) were 39.7% and 52.6% in anemic women, 
significantly more frequent than 23.9% and 35.0%, respectively in non-anemic 
subjects; as were subnormal retinol and subnormal ascorbic acid. Subnormal 
riboflavin and vitamin B12 showed a high prevalence both in anemic and non-anemic 
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pregnant women. Thus, subnormal concentrations of iron and micronutrients in 
combination may contribute to the higher prevalence of anemia and iron deficiency 
anemia (Chapter 3).  
Based on the findings in Chapter 2 and 3, we conducted a 2-mo randomized double-
blind trial among 366 anemic pregnant women (Hb<105g/L) in the period from 
October 2003 to May 2005. They were supplemented with retinol and/or riboflavin on 
top of iron and folic acid in Chapter 4. The increase of Hb concentration was greatest 
in the combination group (5.4g/L). The residual prevalence of anemia after 
supplementation with iron and folic acid alone was halved by adding retinol and 
riboflavin. We also observed favorable effects of riboflavin and retinol on 
gastrointestinal symptoms like nausea, abdominal discomfort and vomiting often 
caused by ferrous sulphate and well-being. Thus, a combination of iron, folic acid, 
retinol and riboflavin was more effective than iron plus folic acid alone.  
 
Pregnancy and iron (over load) might enhance levels of oxidative stress produced by 
reactive oxygen species (ROS), which is harmful to the fetus and the pregnant 
woman and may cause a reduction in erythrocyte membrane fluidity. We carried out 
a 2-mo supplementation trial among 164 anemic pregnant women in 2004-2006. 
Four groups were compared: placebo; iron; iron plus folic acid; iron plus folic acid, 
retinol and riboflavin (Chapter 5). Considerable improvements of hematological 
parameters, and significant increase of glutathione peroxidase activities (GSH-px) 
and decrease of malondialdehyde (MDA) were observed in all three intervention 
groups compared to the placebo. Moreover, fluorescence polarisation (ρ) and 
microviscosity (η), indicators of membrane fluidity decreased significantly after 2 
months of supplementation. Supplementation with iron and particularly in 
combination with vitamins improved hematologic status as well as oxidative stress 
and erythrocyte membrane fluidity. 
In any context of iron supplementation in the prenatal prophylaxis or therapeutic 
dosage range, iron supplements might cause increased oxidation. Therefore, a third 
trial was conducted among subjects of 153 anemic pregnant women, from 2003 to 
2005 (Chapter 6). Its aim was to compare effects of moderate amounts of two often 
used forms of iron supplements, i.e. ferrous sulphate (FeSO4) and NaFeEDTA, in 
improving hematological status and oxidative stress. We found that iron deficiency 
among pregnant women untreated in the second trimester of pregnancy 
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deterioratedin the third trimester both with respect to hematologic status and 
oxidative stress. However, after iron supplementation, hematologic indicators, such 
as plasma iron, Hb and ferritin, considerably increased; and also GSH-Px activities 
increased and MDA levels decreased in both intervention groups compared with 
placebo. Sodium iron EDTA supplementation induced significantly greater changes in 
plasma iron, ferritin and GSH-Px activity. Thus, iron supplementation seems to 
improve both iron deficiency and oxidative stress in anemic pregnant women, and 
NaFeEDTA performs better than ferrous sulfate. 
 
In conclusion, this thesis is a series of studies, involving descriptive studies and 
supplementation trials. Anemia appeared to be a severe public health problem in 
pregnant women in poor rural areas. We observed favorable effects of iron 
supplementation and even better of iron combined with other micronutrients on 
anemia and on measures of oxidative stress. Thus, our study has important public 
health implications. It underlines the need for a comprehensive nutritional policy for 
this target population. Besides improving their dietary intake, multiple micronutrients 
in pregnant women in rural China should be recommended. 
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Samenvating 
 
Anemie (bloedarmoede) is de gesel van de derde wereld. Zwangere vrouwen zijn 
hier vatbaar voor, vooral in het laatste trimester van de zwangerschap. Tussen 1995 
en 2000 was de prevalentie van anemie (Hb<110g/L) in urbane gebieden bij Chinese 
vrouwen in het derde trimester van de zwangerschap 48%. Ondanks het feit dat de 
diagnose van anemie vrij eenvoudig is te stellen en de behandeling goedkoop, was 
de algehele prevalentie van anemie onder zwangere vrouwen in Jiangsu en 
Zhejiang, provincies met het hoogste economische niveau, over de periode 1993-
2005, gemiddeld 39,6%. Dit was 29,6 in het eerste, 33,0 in het tweede en 56,2 in het 
derde trimester. In rurale gebieden is anemie mogelijk zelfs nog steeds een erstiger 
volksgezondheidsprobleem bij zwangere vouwen in het derde trimester vanwege 
onvoldoende ijzerinname, maar ook als gevolg van andere micronutriënt deficiënties. 
Om die reden hebben we een dwarsdoorsnede-onderzoek uitgevoerd om de situatie 
bij zwangere vrouwen in rurale gebieden in China te onderzoeken. Bovendien 
hebben we drie suppletietrials uitgevoerd met ijzer en micronutrienten om het effect 
hiervan op anemie en micronutriëntenstatus vast te stelen en om mogelijke 
bijwerkingen te evalueren.  
De prevalentie van ijzergebreksanemie en micronutientendeficiënties bij zwangere 
vrouwen in rurale gebieden op nationale schaal is niet goed bekend. Van 1999 tot 
2003 hebben we een grote populatiestudie uitgevoerd in vijf rurale gebieden, 
namelijk Qingdao in het oosten, Fuzhou in het zuidoosten, Lanzhou in het 
noordwesten, Guilin in het zuidwesten en een buitengebied van Liaocheng in 
centraal China. Dit zijn allemaal onderontwikkelde gebieden met verschillende 
geografische condities. In totaal 6413 zwangere vrouwen werden gerecruteerd, bij 
wie de prevalentie van anemie overall 58,6 was met een range van 48,1 tot 70.5 in 
de vijf gebieden (Hoofdstuk 2). 
Tevens evalueerden we bij een random subgroep van de deelneemsters de 
micronutriëntenstatus, om vast te stellen of deficiënties van meerdere nutriënten 
tezamen voorkomen bij zwangere vrouwen met anemie. De bevindingen lieten zien 
dat de micronutriëntenstatus van anemische zwangere vrouwen lager was dan die 
van niet-anemische vrouwen. De prevalenties van verlaagd serum ijzer (<700μg/L) 
en ijzerdepletie (ferritine<12μg/L) waren bij anemische vrouwen met 39,7% en 52,6% 
significant hoger dan bij niet-anemische vrouwen met respectievelijk 23,9% en 
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35,0%, evenals verlaagd serum retinol en ascorbinezuur. Verlaagd riboflavine en 
vitamine B12 kwamen frequent voor bij zowel anemische als niet-anemische 
zwangere vrouwen. Derhalve dragen subnormale concentraties ijzer en andere 
micronutriënten mogelijk bij aan de hoge prevalentie van anemie (Hoofdstuk 3).  
 
Op basis van de bevindingen in Hoofdstuk 2 en 3, hebben we een twee maanden 
durende dubbelblinde trial uitgevoerd bij 366 anemische zwangere vrouwen 
(Hb<105g/L) in de periode van oktober 2003 tot mei 2005. De vrouwen kregen 
supplementen met retinol en/of riboflavine, dan wel placebo, tegen een achtergrond 
van ijzer en foliumzuur (Hoofdstuk 4). De stijging van de Hb concentratie was het 
grootst in de combinatiegroep (5,4g/L). De prevalentie van anemie die overbleef na 
suppletie met alleen ijzer en foliumzuur, werd gehalveerd bij toevoegen van retinol en 
riboflavine. We vonden ook gunstige effecten van riboflavine en retinol op maag-
darmverschijnselen zoals misselijkheid, buikpijn en braken, bekende bijwerkingen 
van ijzersulfaat, en op welbevinden. Een combinatie van ijzer, foliumzuur, retinol en 
riboflavine was dus effectiever dan alleen ijzer en foliumzuur.  
 
Zwangerschap en (overdaad aan) ijzer kunnen mogelijk bijdragen aan oxidatieve 
stress veroorzaakt door zuurstofradicalen, Dit kan schade toebrengen aan de 
zwangere vrouw en het ongeboren kind en een verlaging van de membraanfluïditeit 
van erythrocyten veroorzaken. In 2004-2006 voerden wij een twee maanden durende 
suppletietrial uit bij 164 zwangere vrouwen met anemie. Vier groepen werden met 
elkaar vergeleken: placebo; ijzer; ijzer plus foliumzuur; en ijzer plus foliumzuur, retinol 
en riboflavine (Hoofdstuk 5). Aanzienlijke verbeteringen ten opzichte van placebo 
werden in alle drie de interventiegroepen waargenomen in hematologische 
prameters, en significante stijgingen in glutathion peroxidase (GSH-px) activiteit en 
daling van malondialdehyde (MDA). Bovendien daalden fluorescentie polarisatie (ρ) 
en microviscositeit (η), indicatoren van membraanfluïditeit, significant na twee 
maanden suppletie. Suppletie met ijzer en vooral in combinatie met de vitaminen, 
verbeterde zowel de hematologische status als de oxidatieve stres en de 
membranfluïditeit van de erythrocyten. 
Prenatale ijzer suppletie, in profylactische of therapeutische doseringen, zou 
toegenomen oxidatie kunnen veroorzaken. Om die reden hebben we een derde trial 
uitgevoerd bij 153 zwangere vrouwen tussen 2003 en 2005 ((Hoofdstuk 6). Het doel 
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was het vergelijken van de effecten van matige hoeveelheden van twee dikwijls 
gebruikte ijzer supplementen (ijzersulfaat (FeSo4) en Na FeEDTA) op de 
hematologische status en op oxidatieve stress. We vonden dat ijzer deficiëntie bij 
vrouwen die in het tweede trimester van de zwangerschap niet waren behandeld  
verergerde in het derde trimester, zowel wat betreft hematologische status als wat 
betreft oxidatieve stress. Na ijzersuppletie stegen hematologische indicatoren zoals 
plasma ijzer, Hb en ferritine aanzienlijk. Tevens steeg de GSH-Px activiteit en daalde 
het MDA-niveau in beide interventiegroepen vergeleken met placebo. NaFeEDTA 
suppletie induceerde significant grotere veranderingen in plasma ijzer, ferritine en 
GSH-Px activiteit. Derhalve lijkt ijzer suppletie zowel ijzerdeficiëntie als oxidatieve 
stress bij zwangere vrouwen met anemie te verbeteren. NaFeEDTA doet het daarbij 
beter dan ijzersulfaat. 
 
Concluderend rapporteert dit proefschrift een serie studies, beschrijvend onderzoek 
en suppletietrials die zijn uitgevoerd in China. Anemie blijkt een ernstig 
volksgezondheidsprobleem te zijn bij zwangere vrouwen in arme rurale gebieden. Wij 
hebben gunstige effecten waargenomen van ijzersuppletie op anemie en op maten 
van oxidatieve stress. De effecten van ijzer gecombineerd met andere 
micronutriënten waren bovendien duidelijk beter. Daarmee hebben onze studies 
belangrijke volksgezondheidsimplicaties. Ze onderstrepen de noodzaak van een 
alomvattend voedingsbeleid voor deze doelpopulatie. Behalve verbeteren van de 
voedingsinname van zwangere vrouwen in rurale gebieden van China, dient 
suppletie met meerdere micronutriënten te worden aanbevolen.  
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论文总结 
(Chinese) 
 
贫血被认为是发展中国家的一种严重营养缺乏病，特别多见于孕晚期妇女。中国
一项调查显示在 1995-2000 年期间城市孕晚期妇女贫血患病率高达 48%。尽管贫血的
诊断简单、治疗也便宜；但对经济较发达的江苏和浙江两省在过去 12 年（即 1993-
2005 年）间孕妇贫血调查发现，贫血总患病率达到 39.6%，其中孕早期为 29.6%，中
期为 33.0%，而孕晚期高达 56.2%。在农村，孕晚期妇女贫血患病情况更加严重，可
能与当地妇女在孕早期、孕中期铁的摄入和利用减少以及其他微量营养素摄入不足有
关。因此，我们设计和开展了三项采用铁剂与其他微量营养素补充剂进行联合补充试
验，目的是改善孕妇贫血和微量营养素缺乏以及观察其他生物学效果。 
到目前为止，中国农村妇女缺铁性贫血及微量营养素不足营养问题的严重程度了
解不多，重视不够。从 1999 年至 2003 年，考虑地域分布我们选择了经济尚不发达甚
至比较落后的山东（青岛莱西和聊城莘县）、福建、兰州、桂林作为调查点，随机选
择了 6413 名孕晚期妇女进行贫血患病情况及维生素等微量营养素状况调查，结果发现
四省五县市孕晚期贫血平均总患病率高达 58.6%，最低为 48.1%，最高达到 70.5%（
见论文第 2 章）。此外，我们同时随机抽取了部分被调查的孕妇血样进行了分析，目
的是了解被检孕妇是否存在某些微量营养素缺乏。结果发现贫血孕妇机体多种微量营
养素水平明显低于非贫血孕妇，血清铁水平不足（血清铁<700μg/L）和铁严重缺乏者
分别达到 39.7%和 52.6%，而非贫血妇女仅为 23.9%和 35.0%。另外，分析发现贫血
孕妇维生素 A、维生素 C 的水平也是比较低的；而贫血孕妇及非贫血孕妇机体维生素
B2 和维生素 B12 都明显不足。因此，调查结果说明孕晚期妇女机体铁和微量营养素的
营养状况是比较差的（见论文第 3 章）。 
本论文在第 2 章和第 3 章调查研究的基础上，设计并在山东莘县开展了三项随机
双盲对照试验干预研究。第一项干预研究（见本论文第 4 章）是 2003-2005 年选取
366 名孕中期贫血（Hb<105g/L）孕妇，采用铁+叶酸（IF）、铁+叶酸+维生素 A 
(IFA)、铁+叶酸+维生素 B2 (IFB)和铁+叶酸+维生素 A+维生素 B2(IFAB)进行干预，为
期 2 个月，结果显示 IFAB 组贫血孕妇血红蛋白水平升高了 5.4g/L,明显高于其他各组
血红蛋白升高的水平。同时，该研究观察到添加维生素 B2组（IFB 和 IFAB）的孕妇因
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铁剂补充产生的胃肠道不良反应得到明显改善，其中精神状况好转，由硫酸亚铁引起
的恶心、呕吐、胃肠不适的表现明显改善。 
有报道认为怀孕和铁过量摄入可能提高机体氧化应激水平，甚至影响红细胞膜氧
化水平及流动性，对胎儿发育和母体健康均有不利影响。因此，本研究开展了第二个
干预试验，在 2004-2006 年期间，选取 164 名孕晚期贫血（Hb<110g/L）妇女，研究
设计对照组、铁组、铁+叶酸组、铁+叶酸+维生素 A+维生素 B2组，补充干预为 2 个月
（见本论文第 5 章）。结果显示除了贫血及相关指标明显好转外，机体氧化应激水平
也得到明显改善，谷胱甘肽过氧化物酶（GSH-px）的活性明显升高，脂质过氧化物
MDA 水平明显减低，红细胞的流动性明显升高，而在多种营养素补充组效果最佳；很
遗憾在对照组孕中期妇女在 2 个月后到达孕晚期表现贫血患病情况更加严重，氧化应
激水平未能得到明显改善。 
贫血治疗和预防的制剂较多，如硫酸亚铁（FeSO4），NaFeEDTA 等；但铁剂
种类和补充剂量、效果，以及是否会影响机体氧化应激水平，国内外报道较少。因此
，设计有 153 名贫血孕妇参与随机双盲对照试验研究，设计对照组、硫酸亚铁组和
NaFeEDTA 组进行补充并比较两者的效果，为期 2 个月（见本论文第 6 章）。结果显
示，对照组孕妇贫血在孕晚期有所加重，氧化应激水平也没明显改善；但是在硫酸亚
铁组和 NaFeEDTA 组孕妇贫血得到明显改善，氧化应激水平明显好转，尤其是 GSH-
px 的活性明显升高， MDA 水平明显减低；与硫酸亚铁的效果相比，NaFeEDTA 制剂
效果更明显。 
总之，本论文是一个系列研究，由描述性流行病学研究到实验流行病学的改善干
预研究，从发现在农村妇女中贫血率较高及其他微量营养素状况较差，到有针对性的
加以改善。通过研究我们发现铁剂补充对改善农村孕妇贫血是有效的，如同时补充或
改善贫血孕妇其他微量营养素的状况可能对改善贫血及提高农村孕妇健康水平效果更
好；因此，建议和推荐农村孕妇应注意膳食平衡，适量补充铁剂和其他微量营养素，
以有效地预防和治疗贫血。 
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